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The first survey on drug use in the general 
population was carried out in Ireland in 2002/3. 
The results were jointly published by the National 
Advisory Committee on Drugs (NACD), now the 
National Advisory Committee on Drugs and 
Alcohol (NACDA), and the Drug and Alcohol 
Information and Research Unit. The survey was 
repeated in 2006/7 and in 2010/11.1 In 2014, the 
NACDA commissioned IPSOS MRBI to conduct 
the Ireland and Northern Ireland drug prevalence 
survey 2014/15.2
The newsletter of 
Ireland’s focal point 
to the EMCDDA
Results from fourth 
general population 
survey on drug use  
in Ireland
L-R: Author of the Evaluation of 
the HSE Naloxone Demonstration 
Project Dr Ann Eustace, Minister 
of State for Communities and 
the National Drugs Strategy, 
Catherine Byrne TD and HSE 
National Director Primary Care 
John Hennessy attending the 
launch of the report (see p. 18)
In brief
Developing and implementing effective 
responses to the drugs situation requires an 
efficient and scientific system of monitoring 
so policy-makers can act using sound and 
dependable information. Ireland is well 
served in terms of the supply of population 
data that allows us to develop detailed and 
reliable pictures describing the extent and 
nature of drug trends over time. Various 
health surveillance systems provide the data 
on which analysis of the consequences of 
problem drug use, and the responses in place 
to alleviate or prevent them, can be built.
A number of articles in this issue illustrate the extent 
to which policy in Ireland is supported by up-to-date, 
robust and comparable data on the drug situation. We 
present the main findings from the recently published 
2014/15 survey on drug use in the general population, 
the fourth iteration of this survey which was first carried 
out in 2002/3. The main focus on the findings of general 
population studies is on the younger cohorts, and 
the information from the general population survey 
is complemented by data from several other sources. 
Another article presents the findings from the Irish 
section of the European School Survey Project on Alcohol 
and Other Drugs (ESPAD) that has conducted surveys 
of school-going children every four years since 1995. 
Findings from general health surveys and longitudinal 
studies provide further insight into patterns of behaviour 
among the 15–34-years age groups.
Policy-makers and service planners need this monitoring 
framework to measure both the overall prevalence 
of drug use and of drug dependency and to make 
predictions around the demand for services based on 
the likely consequences of these prevalence levels. While 
such data is essential for the creation of an accurate 
picture of the overall drugs situation, effective targeting 
of resources, particularly in the demand reduction area, 
requires both a broader selection of data sources and 
a narrower focus in terms of subject. Recent analysis 
of data from the Dunedin Longitudinal Study in New 
Zealand demonstrates that the risk factors leading to 
greater use of health, social and security services in 
adulthood can be identified at a very young age. Details 
on personal circumstances combined with demographic 
information are clearly associated with a range of health 
and behavioural problems, including substance use, 
later in life. Creative use of existing datasets will enable 
researchers to define these patterns more clearly and 
provide information which can be used to help services 
to become more targeted and effective.
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Similarly, last year and last month prevalence of any illegal 
drug use has increased since the previous survey; from 7% to 
9% and 3% to 5%, respectively. Any illegal drug refers to the 
use of cannabis, ecstasy, cocaine powder, magic mushrooms, 
amphetamines, poppers, LSD, new psychoactive substances 
(NPS), solvents, crack and heroin.
Illicit drug use was more prevalent in males, and was also 
greater among young adults, with almost 9% of persons 
aged 15–34 years having reported illegal drug use within the 
previous month (compared to 5% in 2010/11). Results from the 
2014/15 survey indicated that the most commonly used illicit 
substances in Ireland, based on last month prevalence, were 
cannabis (4%), ecstasy (1%) and cocaine (0.5%).
Cannabis use
Findings revealed that 28% of the population (15–64 years) 
had used cannabis at some point in their lives; 8% reported 
use in the year prior to the survey; and 4% indicated use in 
the preceding month. All of these rates are higher than those 
recorded in previous surveys within Ireland (Figure 2).
The 2014/15 survey followed best practice guidelines 
recommended by the European Monitoring Centre for  
Drugs and Drug Addiction (EMCDDA). The questionnaire, based 
on the European Model Questionnaire, was administered in 
face-to-face interviews with respondents aged 15+ years.  
A sample comprising all households throughout the island of 
Ireland was randomly selected to participate and fieldwork 
began in September 2014 and was completed in May 2015. Of 
the household members contacted, 7005 agreed to take part. 
The sample was weighted by gender, age and region to ensure 
that it was representative of the general population. The main 
measures were lifetime (ever used) use, use in the last year 
(recent use) and use in the last month (current use). 
Use of any illegal drug
The proportion of respondents aged 15–64 years who reported 
using any illicit drug in their lifetime has increased from 19% 
in 2002/3 to almost 31% in 2014/15 (Figure 1). There has also 
been an increase when compared to the 2010/11 study (27%). 
General population survey continued
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Figure 1: Lifetime, last year and last month prevalence of any* illicit drug use in Ireland, 2002/3, 2006/7, 2010/11 and 2014/15 
Source: NACDA, 2016
*Any illicit drug refers to the use of cannabis, ecstasy, cocaine powder, magic mushrooms, amphetamines, pop-
pers, LSD, new psychoactive substances, solvents, crack and heroin
Figure 2: Lifetime, last year and last month prevalence of cannabis use in Ireland, 2002/3, 2006/7, 2010/11 and 2014/15
Source: NACDA, 2016 
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17 Cocaine use 
Lifetime cocaine use has increased when compared to 2010/11 
(Figure 3). The percentage of respondents aged 15–64 years 
who reported using cocaine (including crack) at some point 
in their lives increased from 7% to 8%. The proportion of 
young adults (15–34 years) who reported using cocaine in their 
lifetimes has also increased from 9% to 11%.
As was observed in previous studies, more men reported using 
cocaine in their lifetimes compared to women (11% vs 5%). 
However, although the lifetime rate of cocaine use among 
persons aged 15–64 years and young adults aged 15–34 years 
has more than doubled since 2002/3, the percentage of 
respondents reporting current use of cocaine has remained 
relatively unchanged across surveys.
Ecstasy use 
In Figure 4, significant increases in lifetime and last year 
prevalence of ecstasy use were observed in persons aged 
15–64 years (7% to 9% and 0.5% to 2%, respectively). 
Similar to earlier studies, rates of cannabis use were greater 
among men than women: (36% vs 20%) lifetime use; (11% 
vs 4%) last year use; and (7% vs 2%) last month use. Since 
2002/3, lifetime rates of cannabis use among males have 
increased by 61% and last month use by 94%. Lifetime use of 
cannabis among females has also increased (20% in 2014/15 vs 
12% in 2002/3). However, last month prevalence in women has 
remained relatively stable over time.
The prevalence of cannabis use was noticeably higher among 
young adults (15–34 years). Lifetime rates were similar to those 
reported in 2010/11 (34%). Last year and last month prevalence 
rates were higher than those recorded in the previous survey 
(14% vs 10% and 8% vs 5%), and the proportion of young adults 
who classified themselves as current users of cannabis has 
almost doubled since 2002/3. Approximately 13% of males and 
6% of females aged 15–34 years indicated that they had used 
cannabis in the month prior to the survey. Lifetime, last year 
and last month rates of cannabis use among adults aged 35-64 
years were 24%, 3% and 2%, respectively.
Figure 3: Lifetime, last year and last month prevalence of cocaine use (including crack) in Ireland, 2002/3, 2006/7, 2010/11 and 2014/15
Source: NACDA, 2016
Figure 4: Lifetime, last year and last month prevalence of ecstasy use in Ireland, 2002/3, 2006/7, 2010/11 and 2014/15
Source: NACDA, 2016 
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the use of cannabis and ecstasy among younger adults, and in 
particular young males. 
Although opioids were included as a drug category in this 
study, the prevalence of heroin use was low, as the Ireland and 
Northern Ireland drug prevalence survey 2014/15 is a general 
population survey. Thus, persons who do not normally reside in 
private households have not been included. A national three-
source capture-recapture (CRC) study to provide statistically 
valid estimates of the prevalence of opiate drug use in the 
national population was commissioned by the NACDA and 
undertaken in 20015 and 2006.6 The three data sources used 
were the Central Treatment List (of clients on methadone), the 
Hospital In-Patient Enquiry (HIPE) scheme, and Garda PULSE 
data. A third study using the CRC method was commissioned in 
2014, and a final report is due to be published shortly.
Seán Millar
1 National Advisory Committee on Drugs (NACD) and Public Health 
Information and Research Branch (PHIRB) (2011) Drug use in 
Ireland and Northern Ireland: first results from the 2010/11 
Drug Prevalence Survey. Bulletin 1. Dublin: NACD and PHIRB. 
http://www.drugsandalcohol.ie/16353/
2  National Advisory Committee on Drugs (NACDA) and Department 
of Health (DoH) UK (2016) Prevalence of Drug Use and Gambling 
in Ireland and Drug Use in Northern Ireland. Bulletin 1. Dublin: 
NACD and DoH. http://www.drugsandalcohol.ie/26364/
3 Long J (2012) Results from the third general population  
survey in Ireland. Drugnet Ireland, 40: 6–8.  
http://www.drugsandalcohol.ie/16866/
4 Criminal Justice (Psychoactive Substances) Act 2010.  
Available online at http://www.irishstatutebook.ie/eli/2010/
act/22/enacted/en/html 
5 Kelly A, Carvalho M and Teljeur C (2003) Prevalence of opiate 
use in Ireland 2000–2001: a 3-source capture recapture study: 
a report to the National Advisory Committee on Drugs Sub-
Committee on Prevalence. Dublin: Stationery Office.  
http://www.drugsandalcohol.ie/5942/
6 Kelly A, Teljeur C and Carvalho M (2009) Prevalence of opiate 
use in Ireland 2006: a 3-source capture recapture study: a 
report to the National Advisory Committee on Drugs. Dublin: 
Stationery Office. http://www.drugsandalcohol.ie/12695/ 
Fourteen per cent of young adults (15–34 years) claimed to 
have tried ecstasy at least once in their lifetime, with over 4% 
having used it within the last year (vs 0.9% in 2010/11) and 2% 
indicating current use (vs 0.1% in 2010/11). Almost 10% of males 
and 4% of females aged 15–24 years reported using ecstasy 
within the previous year, while current use was 4% (males) and 
approximately 3% (females) for the same age category.
Previous findings from the 2010/11 survey had suggested a 
decline in the use of ecstasy among younger Irish adults when 
compared to earlier studies. This was possibly due to the 
increased use of NPS sold in head shops and online.3
New psychoactive substances (NPS)
In 2014/15, the lifetime prevalence of NPS use among 
respondents aged 15–64 years was approximately 4%, while 
last month prevalence was less than 1%. In male adults 
aged 35-44 years, and those aged 45–54 years, lifetime 
prevalence rates were 3% for both. For females, the 
corresponding rates were 1.2% and 0.9%, respectively. Last 
month prevalence of NPS use for both age categories was 
less than 1% in both genders.
Last year prevalence of NPS use was included as a drug 
category for the first time in the 2010/11 NACDA drug 
prevalence survey. In contrast to trends observed with other 
illicit substances, data from the 2014/15 study demonstrate 
a reduction in the use of NPS in the Irish population in both 
genders (Figure 5). The percentage of male and female young 
adults aged 15–24 years who indicated current use of NPS was 
also less than 1%.
The low prevalence of current NPS use among younger Irish 
adults, and decreasing trends in NPS use among respondents 
aged 15–64 years of both genders, may be as a result of the 
Criminal Justice (Psychoactive Substances) Act 2010, which 
came into effect in August 2010. The Act made it an offence, 
punishable by up to five years’ imprisonment, to sell or supply 
for human consumption substances which are not specifically 
proscribed under the Misuse of Drugs Acts, but which have 
psychoactive effects.4 
Nevertheless, despite a decline in the use of NPS, the results 
from the 2014/15 survey indicate an increase in the use of illicit 
substances within Ireland. This is largely due to an increase in 
Figure 5: Last year prevalence of NPS use among adults in Ireland, 2010/11 and 2014/15
Source: NACDA, 2016
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17 Central to the judgement in October was the question 
whether or not MUP was a proportionate policy under EU law 
– in other words, are there more public health benefits to 
be achieved by introducing MUP than could be achieved by 
other existing policy options, in particular increased taxation 
on alcohol? Those opposing MUP argued that changes in 
taxation would be a more suitable course of action. However, 
in delivering its ruling, the court stated that:
The fundamental problem with an increase in 
tax is simply that it does not produce a minimum 
price [para. 196] …. The advantage of the proposed 
minimum pricing system, so far as protecting health 
and life is concerned, is that it is linked to the 
strength of the alcohol. Current EU tax arrangements 
relate to different types of product (wine, spirits, 
beer and cider etc) each of which has a range of 
ABVs .… they do not permit taxation of wines at 
variable rates according to the strength of alcoholic 
content. Minimum pricing permits lower pricing to 
be charged for lower strength alcohol [para. 198].1
While the ruling paved the way for the Scottish government 
to implement the Act, in November 2016 the Scotch Whisky 
Association launched an appeal on the decision to the UK 
Supreme Court in London.
Lucy Dillon
1 The full Court of Session judgement is available online 
at https://www.scotcourts.gov.uk/search-judgments/
judgment?id=9a1821a7-8980-69d2-b500-ff0000d74aa7
2 For a discussion on the Sheffield research applied to the Irish 
context, see Drugnet Ireland, 56, ‘Minimum unit pricing for alcohol: 
what will it really mean?’. http://www.drugsandalcohol.ie/25136/
POLICY AND LEGISLATION 
Minimum unit  
pricing backed by 
courts in Scotland
On 21 October 2016, the Court of Session in Edinburgh ruled 
against a challenge to the introduction of minimum unit 
pricing (MUP) in Scotland, brought by the Scotch Whisky 
Association and others.1 Essentially, the case concerned a 
measure (MUP) that the Scottish government argued would 
help to reduce alcohol-related harm, while the producers 
and sellers of alcohol argued that it inhibited their right by 
law to trade freely across the EU.
The Alcohol (Minimum Pricing) (Scotland) Act was passed in 
June 2012: 86 members of the Scottish Parliament voted in 
its favour, one voted against and 32 abstained. In line with 
the Act, the minimum price was to be calculated according 
to a formula: MPU × S × V × 100 (minimum price per unit × 
strength of the alcohol × volume of the alcohol in litres). In 
2013, Scotland set the MUP at 50p (approx. 55c) – a 70cl bottle 
of spirits with an ABV (alcohol by volume) of 40% would retail 
at a minimum of £14 (€15.50). This formula and the case for 
introducing MUP more broadly were informed by research 
conducted by experts from the Sheffield Alcohol Research 
Group (SARG) at the University of Sheffield. These experts have 
also applied their modelling to the Irish context.2
policy discussions. Their second main goal is to promote 
evidence-based policies aimed at ‘effectively preventing and 
reducing the burden of alcohol’. Based on the World Health 
Organization’s strategy, Eurocare’s motto is ‘less is better’. 
Skar highlighted that there is no current EU alcohol strategy. 
Despite the European Parliament passing a resolution on the 
alcohol strategy, she thought it ‘highly doubtful’ that one 
would result. However, she described European-level non-
governmental organisation (NGO) collaboration on alcohol as 
‘good’ and recommended that they focus on cross-border 
issues. She also spoke about alcohol pricing, marketing and 
advertising regulations, consumer information, drink driving, 
and data gathering and monitoring.
‘Monitoring and evaluating Scotland’s  
alcohol strategy (MESAS) 2016: evaluating 
Scottish alcohol policy’, Clare Beeston,  
NHS Health Scotland 
Scotland has a multi-component alcohol strategy that 
makes its evaluation difficult. Beeston described the 
theory of change approach underpinning the evaluation 
and its strengths and weaknesses. She also identified 
a number of conclusions that could be drawn from the 
evaluation. It found a decline in population consumption 
of alcohol between 2009 and 2012, as well as a reduction 
in alcohol-related death rates and hospitalisations since 
their peak in the mid-2000s. Overall, MESAS found that the 
implementation of the alcohol strategy has led to some 
Alcohol policy in 
Ireland and Scotland
On 2 March 2016, Scottish Health Action on Alcohol Problems 
(SHAAP), Alcohol Focus Scotland and Eurocare held a joint 
event in Edinburgh to discuss alcohol policy in Scotland 
and Ireland. They subsequently published the proceedings 
of the event in Alcohol policy in Scotland and Ireland: 
European trailblazers or Celtic fringes?1 The event came 
about as governments in both countries promoted policies 
that focused on increasing the price of alcohol, reducing 
its availability, and restricting its marketing. Similarly, both 
governments were seen to face sustained opposition from 
global alcohol producers in implementing these policies.
The published proceedings contain the five papers presented 
on the day and notes from the final discussion session.
‘Europe and alcohol: challenges and 
opportunities’, Marian Skar, Eurocare:  
The European Alcohol Policy Alliance 
Eurocare’s main goal is to raise awareness among EU 
decision-makers about the social, health and economic 
harms caused by alcohol. They aim to ensure that these 
harms are taken into consideration in all relevant EU 
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positive change in intermediate outcomes. However,  
Beeston also expressed concern about the finding that 
alcohol consumption is flattening and that there has been no 
further decline in mortality or morbidity in the last two years.
‘Whisky galore? Policy challenges and 
priorities in Scotland’, Alison Douglas,  
chief executive, Alcohol Focus Scotland
Douglas described the pattern of alcohol consumption in 
Scotland, highlighting the widespread harms experienced 
in particular in deprived communities. She argued that in 
terms of cost-effectiveness of interventions to reduce 
consumption and harm, the three ‘best buys’ were to take 
action on alcohol pricing, availability, and marketing. They 
were to be seen as mutually reinforcing and should therefore 
be implemented ‘collectively’.
‘Finding the right measure? Policy challenges 
and priorities in Ireland’, Suzanne Costello, 
chief executive, Alcohol Action Ireland 
Costello described Irish alcohol consumption patterns, 
emphasising that ‘binge drinking is a real problem in 
Ireland’. Alcohol-related harms were highlighted, including 
alcohol-related deaths, and their role in deaths by 
suicide in Ireland. Addressing Ireland’s drinking ‘culture’ 
was described as presenting a particular challenge. As 
with previous speakers, she identified alcohol pricing, 
availability, consumer information, and advertising and 
marketing as requiring action if consumption and harms 
were to be addressed. These reflected some of the key 
elements of the Public Health (Alcohol) Bill 2015 that was 
described, including the use of product labels to contain 
a link to a public health website providing information on 
alcohol and its related harms. She concluded that at the 
time of presenting, the Irish political landscape was ‘much 
more favourable to health issues’.
Lucy Dillon
1 Scottish Health Action on Alcohol Problems (2016) Alcohol 
policy in Scotland and Ireland: European trailblazers or Celtic 
fringes? Edinburgh: Scottish Health Action on Alcohol Problems. 
http://www.drugsandalcohol.ie/26101/
In collaboration with the housing sector, the problem of 
finding accommodation for high-risk sex offenders will also 
be addressed. Future explorations will examine the viability 
of expanding the SORAM model to include other offences.
Sharing good interagency information
The intention is to explore other opportunities for sharing 
information among agencies:  
• AGS will provide ‘précis of evidence’ nationwide (p. 4) to 
assist preparation of pre-sanction reports.
• Protocols will be agreed by the IPS and PS regarding 
confidentiality on the sharing of pre-sanction assessment 
reports.
• Agreements will be made by AGS with the PS and IPS to 
allow Gardaí access to information on offenders who are 
on probation and in prison.
• Agencies will ensure that information is shared regarding 
prisoners who are unlawfully at large.
Creating more efficient system of 
implementing court orders
The PS and AGS will be responsible for outlining a course of 
action to deal with cases not meeting the terms of court 
orders and warrants issued as a result of non-cooperation. 
A system will be created to keep a record of warrants issued 
and how they can be retrieved and implemented.
Addressing consequences of domestic 
violence in communities
In order to deal with domestic violence, the aim is to develop 
stronger ties, common language and understanding between 
AGS, the IPS and PS. This will include the use of warning 
systems, joint training, and exchanging information on how to 
assess and manage offenders. 
Joint Strategy  
on the Management 
of Offenders
On 22 September 2016, the Tánaiste and Minister for Justice 
and Equality, Frances Fitzgerald TD launched the first Joint 
Strategy for the Management of Offenders.1 The strategy, 
which builds on existing collaborative work between the 
Irish Prison Service (IPS), the Probation Service (PS) and 
An Garda Síochána (AGS), highlights two areas, namely the 
management of offenders along with a strong focus on 
the rights of victims. What follows is an outline of the main 
objectives and accompanying actions to go forward between 
2016 and 2018.
More integrated management
It was announced that the Joint Agency Response to  
Crime (JARC) would be extended into three more areas: 
Dundalk, Waterford City and Limerick City. JARC will 
be evaluated to inform future developments and an 
online platform E-JARC will be developed to support 
communication between agencies. Engagement by the  
IPS, the PS and AGS with the Courts Service will aim to 
produce shared information technology.
Multi-agency response to management  
of sex offenders
The Department of Justice and Equality intends to have the 
Sex Offender Risk Assessment and Management (SORAM) 
model ratified legally. SORAM will then be officially launched 
via a national conference. The research findings of the initial 
pilot will inform how SORAM will be implemented nationally. 
Alcohol policy in Ireland  
and Scotland continued
8
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17 Joint Strategy on the 
Management of Offenders continued
(4) new challenges, threats and realities; and (5) drugs and 
development. The summaries include a focus on the input of 
civil society representatives, and highlight where there was a 
lack of consensus between country representatives.
In addition to the summaries, the report provides an overall 
critique of the UNGASS process. From the outset, the 
IDPC is critical of the central role of the pre-negotiated 
UNGASS outcome statement.4 It describes it as having being 
negotiated through a process characterised by a ‘lack of 
transparency and accountability’. By virtue of the document 
having been essentially finalised prior to UNGASS, ‘a number 
of barriers were in place to hinder civil society participation. 
This all served to ensure that the UNGASS was not the drug 
policy revolution that some stakeholders seemed to be 
expecting’. The report also describes barriers to civil society 
participating at the UNGASS event itself. For example: the 
restrictions and censorship placed on their distribution of 
literature and reports; and access to sessions being denied 
to a significant number of civil society attendees on the day, 
despite having previously confirmed attendance. Despite 
these barriers, the IDPC argues that ‘the voice of civil 
society – including affected populations such as people who 
use drugs – was strongly heard at the UNGASS, both in the 
preparations and the meeting itself’.
While the report tends to be critical of the UNGASS outcome 
statement, the IDPC also concedes that it ‘undoubtedly 
takes a step forward from previous commitments [at UN 
level] – not least in terms of access to medicines, human 
rights, overdose prevention and proportionate sentencing’. 
Responses to 
UNGASS 2016
The United Nations General Assembly Special Session 
(UNGASS) on the world drug problem was held in April 2016. 
It attracted formal responses from a variety of civil society 
bodies working in the area of drug policy. This article looks at 
responses from two of these bodies – the International Drug 
Policy Consortium (IDPC) and the Global Commission on Drug 
Policy (GCDP). UNGASS-related publications by these bodies 
were included in earlier issues of Drugnet Ireland, as part of 
the ‘Towards UNGASS 2016’ column.1 
International Drug Policy Consortium
The IDPC is a global network of 163 NGOs. It focuses on 
issues related to drug production, trafficking and use, and 
promoting objective and open debate on the effectiveness, 
direction and content of drug policies at national and 
international levels. The network supports evidence-based 
policies that are effective at reducing drug-related harm.2
In September 2016, the IDPC published its version of the 
proceedings of the UNGASS.3 The document provides a 
summary of each of the sessions held – the plenary and 
the five roundtable discussions on: (1) drugs and health; 
(2) drugs and crime; (3) cross-cutting issues: drugs and 
human rights, youth, women, children and communities; 
Agencies will continue to work with Tusla to detect and 
manage child protection cases and with COSC (the National 
Office for the Prevention of Domestic, Sexual and Gender-
based Violence) to help support intervention programmes 
for offenders of domestic violence.
Benefits of joint training at operational  
and management levels 
It is proposed that training exchanges will be developed 
between AGS, the PS and IPS. Joint training will be 
undertaken by these agencies in areas such as domestic 
violence, management of sex offenders, and awareness of 
radicalisation to violent extremism.
Reintegration and community management  
of vulnerable offenders
The IPS and PS will continue to develop the reintegration of 
vulnerable prisoners and the Irish Prison Service / Central 
Mental Hospital Court diversion programmes. These agencies 
will also work with the Health Service Executive to enhance 
existing practice protocols.
Advancing North–South cooperation
The intention is to continue the sharing of information 
between agencies in Northern Ireland and the Republic. In 
addition, agencies will attend the annual Public Protection 
Advisory Group seminar to share information with the view  
to improving current practice.
Protecting victims of crime and upholding  
their rights
The PS, IPS, AGS and Department of Justice and Equality will 
attend a specially convened meeting that aims to develop a 
unified approach to working with victims of crime. A close 
working relationship between agencies will ensure that 
obligations under the EU Victims Directive are met. The 
Victim Service teams of these agencies will collaborate and 
develop suitable codes of behaviour for responding to the 
rights and needs of victims.
Minister Fitzgerald welcomed ‘the commitment in the 
strategy of all three agencies to work together to address 
the serious consequences of domestic violence in our 
community; this heinous crime in our community can only be 
reduced with the dedicated focus outlined in the strategy’.2
Ciara H Guiney
1 Department of Justice and Equality (2016) Joint strategy  
on the management of offenders 2016–2018. Dublin: 
Department of Justice and Equality. Available online at  
http://www.drugsandalcohol.ie/26661/
2 Department of Justice and Equality (2016) Tánaiste launches 
Joint Strategy on the Management of Offenders and announces 
the extension of Joint Agency (JARC) initiative to Dundalk, 
Limerick city and Waterford city. Available online at  
http://www.justice.ie/en/JELR/Pages/Extension-of-Joint-
Agency-J-ARC-initiative 
 
9
Issue 60
 | W
inter 20
17      drugnet IR
ELAN
D
      
The GCDP criticised UNGASS for not seriously addressing 
what it sees as ‘the critical flaws of international drug policy’, 
including the criminalisation of drug users; the use of capital 
punishment for drug-related offences; and, the World Health 
Organization’s scheduling system of drugs. It also identified 
UNGASS as having failed both to advocate for harm reduction 
and treatment strategies that have been found to be 
effective and to offer proposals to regulate drugs and ‘put 
governments – rather than criminals – in control’.
The GCDP identified the outcome document as failing 
to recognise the considerable support for change 
demonstrated by many governments and civil society 
groups, and the ‘many positive drug policy reforms already 
underway around the world’. It described as vital that 
the tensions between the restrictions imposed by the 
international narcotics conventions and ongoing initiatives 
on the ground are resolved. In conclusion, it encourages 
and supports governments and civil societies in their efforts 
‘to fundamentally realign drug policy so that health, citizen 
safety and human rights are paramount’.
Lucy Dillon
1 International Drug Policy Consortium:  
http://www.drugsandalcohol.ie/25130/; Global Commission  
on Drug Policy: http://www.drugsandalcohol.ie/23301/ and 
http://www.drugsandalcohol.ie/23684/
2 For more information on the International Drug Policy Consortium, 
visit http://idpc.net
3 The United Nations General Assembly Special Session (UNGASS) 
on the world drug problem: report of proceedings (2016). IDPC: 
London. http://www.drugsandalcohol.ie/26049/
4 As outlined in issue 58 of Drugnet Ireland (http://www.
drugsandalcohol.ie/25954/), two key policy statements to emerge 
from the UNGASS process were: the EU common position; and the 
UNGASS outcome statement. The UNGASS outcome statement 
was agreed by member states at the 59th meeting of the UN 
Commission on Narcotic Drugs (CND) in Vienna in March 2016, and 
was adopted at the start of the UNGASS. 
5 For more information on the Global Commission on Drug Policy, 
visit http://www.globalcommissionondrugs.org 
6 Public statement by the Global Commission on Drug Policy 
on UNGASS 2016 (2016). Available online at http://www.
globalcommissionondrugs.org/wp-content/uploads/2016/04/
FINALpublicstatementforGCDP.pdf
However, based on other elements of the UNGASS (e.g. 
the roundtable and plenary sessions, and inputs from civil 
society and country statements), it describes the so-called 
‘Vienna Consensus’ (manifest in the outcome document) as 
‘irreversibly shattered’ in light of the ‘divergent stances’ of 
member states – it described these as ‘impossible to ignore 
on key issues such as the death penalty, decriminalisation, 
regulated markets and development’. 
In conclusion, the report identified that:
The challenge now for the drug policy reform sector 
is to maintain the momentum and attention which 
the UNGASS managed to achieve – within the UN, 
the media and broader civil society. This requires 
a concerted effort to keep the fire burning, rather 
than leaving it to burn out and to build on the steps 
forward and lessons learned to ensure further 
significant shifts in 2019 or 2020 [at the next UN 
review of the drug problem]. 
Global Commission on Drug Policy
The GCDP describes itself as made up of 25 political leaders 
and leading thinkers from across the political spectrum. 
It sets out to ‘bring to the international level an informed, 
science-based discussion about humane and effective 
ways to reduce the harm caused by drugs to people and 
societies’.5 
On the final day of the UNGASS, the GCDP issued a public 
statement on the event.6 It described itself as ‘profoundly 
disappointed’ with the adopted UNGASS outcome statement. 
It argued that: 
The document does not acknowledge the 
comprehensive failure of the current drug control 
regime to reduce drug supply and demand. Nor does 
the outcome document account for the damaging 
effects of outdated policies on violence and 
corruption as well as on population health, human 
rights and wellbeing. 
The UNGASS outcome statement was perceived to have 
sustained ‘an unacceptable and outdated legal status quo’ 
by reaffirming the three international conventions as ‘the 
cornerstone of global drug policy’. 
Responses to UNGASS 2016 
continued
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17 PREVALENCE AND CURRENT SITUATION
Sixth ESPAD survey 
report published
The European School Survey Project on Alcohol and Other 
Drugs (ESPAD) has conducted surveys of school-going 
children every four years since 1995 using a standardised 
method and a common questionnaire. The sixth survey 
was undertaken in 35 European countries during 2014/15 
and collected information on alcohol, tobacco and other 
substance use among 15–16-year-old students.
An important goal of the ESPAD survey is to monitor trends 
in alcohol consumption, tobacco and other drug use among 
15–16-year-olds and to compare trends between countries 
and groups of countries. It also provides an opportunity to 
observe changes in trends in Ireland over the six waves of 
the past 20 years. The rationale for the ESPAD surveys is that 
school students are easily accessible and at an age when the 
onset of substance use is likely to occur. 
This article concentrates on findings from the survey 
conducted in Ireland in 2014/15, in which 2036 
questionnaires were completed by young people from 
50 randomly selected post-primary schools.1 Of these 
participants, 1493 were born in 1999 and will be included in 
the international ESPAD dataset.
Alcohol use
Respondents were asked on how many occasions in their 
lifetime had they used alcohol. Just over one-quarter 
(26.4%) answered that they had never consumed an alcoholic 
beverage in their lifetime. Overall, 73.6% of students had 
drunk alcohol in their lifetime, with almost 20% having tried 
alcohol once or twice. Sixteen per cent had drunk alcohol 
on more than 20 occasions. Significant gender differences in 
lifetime use of alcohol were noted, with more female (75.3%) 
than male (72%) respondents having ever consumed alcohol. 
Male students, however, were more likely to have tried 
alcohol 40 times or more (10.7%) than females (7.5%).
Thirty-six per cent of students had drunk alcohol in the past 
30 days and were considered to be current drinkers. Twenty-
one per cent reported drinking alcohol once or twice in the 
past 30 days, while only a small proportion of respondents 
had used alcohol 10 times or more (3.4%). Similar to lifetime 
use, more female (37.1%) than male (34.9%) students 
indicated current alcohol use. Nevertheless, overall, current 
alcohol use among students in Ireland has declined (Table 1), 
with a 28% reduction since 2011 and a 48% reduction over 
the past 20 years. 
Respondents who drank alcohol were asked to rate their 
level of intoxication. Fourteen per cent of students reported 
being drunk in the past 30 days and 40 students reported 
being drunk more than once or twice during the past month 
(3.0%). A similar number of male (14.7%) and female (13.2%) 
students reported being drunk in the past month and 
there was no significant difference in mean score on the 
drunkenness scale between male (Mean=3.20, SD=1.848) and 
female (Mean=3.12, SD=1.742) students.
Table 1: Alcohol use in the past 30 days among  
15–16-year-olds in Ireland since 2003 
Alcohol use in the 
past 30 days
2003
(%)
2007
(%)
2011
(%)
2015
(%)
Males 71 57 48 35
Females 74 56 52 37
All subjects 73 56 50 36
Source: ESPAD Ireland, 2016
Beer (28.6%), spirits (24.5%) and cider (21.3%) were the most 
common types of alcohol consumed in the month prior to 
the survey. The least popular drinks were wine (11.9%) and 
alcopops (11.4%). Respondents were asked how difficult they 
thought it would be to obtain specific alcoholic beverages, 
with response categories ranging from ‘impossible’ to ‘very 
easy’. A majority of students believed that it would be fairly 
easy to obtain all beverage types examined; 37.8% gave this 
answer for beer and 34.7% for cider. A high percentage of 
students also said it would be very easy to get beer (31.9%) 
or cider (30.2%), while only 5.2% said it would be impossible 
to get beer, with 7% reporting that it would be fairly difficult. 
Respondents believed that it would be slightly more difficult 
to obtain wine and spirits, with a larger number reporting 
that it would be fairly or very difficult, and fewer perceiving 
that it would be fairly easy or very easy.
Smoking
Participants were asked on how many occasions had they 
smoked cigarettes during their lifetimes. More than two-
thirds of students reported that they had never smoked a 
cigarette and a further 10.4% had only smoked on one or two 
occasions. Eight per cent of all students reported smoking 
on at least 40 occasions. Overall, almost one-third had ever 
smoked in their lifetime (32.3%). 
When students were asked to consider how often they 
smoked in the past 30 days, 87% reported that they had not 
smoked at all, while 13% had smoked at least once. Almost 
7% of students reported smoking less than one cigarette 
per day and a further 5.7% smoked between one and 20 
cigarettes per day. Ten students reported smoking more than 
20 cigarettes a day. While the proportion of male and female 
students who had ever smoked was similar, there were 
gender differences in the intensity of smoking behaviours. 
More males reported smoking daily and smoking more 
cigarettes per day than females, while more female students 
smoked less frequently than every day.
Trends over time demonstrate that current smoking among 
school-aged children in Ireland is greatly reduced when 
compared to previous ESPAD surveys. This represents a 
reduction of over two-thirds (68%) since the first survey was 
conducted in 1995, and a 38% reduction over the previous 
four years (Table 2).
Table 2: Smoking in the past 30 days among  
15–16-year-olds in Ireland since 2003 
30-day  
cigarette use
2003
(%)
2007
(%)
2011
(%)
2015
(%)
Males 28 19 19 13
Females 37 27 23 13
All subjects 33 23 21 13
Source: ESPAD Ireland, 2016
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Over 60% of students perceived obtaining cigarettes as 
either fairly easy or very easy, and male students believed 
it would be easier to access cigarettes than females. Most 
students believed that there is a moderate risk (34%) or a 
slight risk (30%) of smoking occasionally, and two-thirds 
answered that they perceived a great risk from smoking one 
or more packs of cigarettes per day.
Other substance use
Students were asked how many times in their lives had they 
used cannabis. Male students (22.4%) were more likely than 
females (15.5%) to have ever tried cannabis. Overall, 19% of 
students had ever tried cannabis, of which most had tried it 
once or twice. There was also a sizeable minority of students 
who smoked cannabis 40 times or more (3.9%). 
Overall, 16.8% of students had used cannabis in the past 12 
months. Again, more male (19.5%) than female respondents 
(13.9%) reported using cannabis in the past year. A small 
number of males (4.1%) reported using cannabis 40 times 
in the past year, suggesting heavier use than female 
respondents (1.2%). Boys were also more likely to have tried 
cannabis at a younger age than girls. Three per cent of boys 
and 1% of girls had first used cannabis at 12 years of age or 
younger. Most students had first tried cannabis at 14 years of 
age (33%) and 15% had first tried it at 13 years. 
When respondents were asked how easy they thought it 
would be to obtain cannabis, 41.9% perceived that it would 
be impossible, very difficult or fairly difficult and 43.4% 
perceived that it would be fairly easy or very easy. 
With regard to lifetime use of other substances, after 
tobacco, alcohol and cannabis, inhalants were the most 
commonly used substance at 10%. The next most regularly 
used drugs were painkillers ‘to get high’ (4%), ecstasy (3%) 
and tranquilisers (3%). In general, however, the prevalence of 
illicit drug use was low.
Trend analysis showed that lifetime use of cannabis in Ireland 
and other ESPAD survey countries stayed approximately the 
same, with a one-percentage point decrease for the ESPAD 
average and a one-percentage point increase for Ireland. 
For Ireland, this represents a drop of almost half since 1995, 
although lifetime prevalence of cannabis use has remained 
relatively unchanged at approximately 20% since 2007 (Table 
3). In Ireland, there was an increase in the lifetime use of 
illicit drugs other than cannabis by one percentage point, 
increasing from 6% to 7%. Overall, however, there has been a 
56% reduction since 1995.
Table 3: Percentage of 15–16-year-olds who reported  
lifetime use of drugs in the ESPAD Irish surveys of 2003,  
2007, 2011 and 2015 
Lifetime use 2003
(%)
2007
(%)
2011
(%)
2015
(%)
Cannabis 39 20 18 19
Illicit substances 
other than  
cannabis
9 10 6 7
Tranquilisers  
(prescribed)
10 10 9 11
Tranquilisers 
(non-prescribed)
23 3 3 3
Inhalants 18 15 9 10
Magic mushrooms 4 4 2 2
Ecstasy 5 4 2 3
Amphetamines 1 3 2 2
LSD 2 3 2 2
Crack 2 4 2 1
Cocaine 3 4 3 2
Heroin 1 1 1 0.4
Source: ESPAD Ireland, 2016
Current trends
In summary, results from the ESPAD 2015 survey suggest a 
decline in the use of alcohol and cigarettes among school-
aged children in the Republic of Ireland. The use of cannabis, 
inhalants and other illicit substances may have stabilised, 
with an overall reduction over the six data collection waves 
from 1995 to 2015. Nevertheless, it should be noted that 
early school-leavers, a group known to be vulnerable to 
alcohol and drug use, are not represented in this survey. 
Consequently, the results may not indicate the true extent of 
alcohol and other illicit substance use among all 15–16-year-
old children within Ireland.
Seán Millar
1 Taylor K, Babineau K, Keogan S, Whelan E and Clancy L (2016) 
ESPAD 2015: European Schools Project on Alcohol and Other 
Drugs in Ireland. Dublin: Department of Health. http://www.
drugsandalcohol.ie/26116/
Sixth ESPAD survey report 
published continued
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17 a rate of 9.8 per 100 000 of population, the highest rate 
recorded since 1995. Since 2006, there has been a general 
increase in the rate of first admissions. It should be noted, 
however, that the report does not present data on drug use 
and psychiatric comorbidity, so it is not possible to determine 
whether or not these admissions were appropriate.
Other notable statistics on admissions for a drug disorder in 
2015 include the following:
• Just under one-half (47.1%) of cases hospitalised for a 
drug disorder stayed less than one week, while 98% were 
discharged within three months. It should be noted that 
admissions and discharges represent episodes or events 
and not persons.
• 11% of first time admissions were involuntary.
• The rate of first time admissions was higher for men  
(14.2 per 100 000 of population) than for women  
(5.4 per 100 000 of population).
The overall increase in the rate of drug-related first 
admissions between 1995 and 2015 may reflect an overall 
increase in problem drug use within Ireland, and its 
increasing burden on psychiatric and mental health services. 
Seán Millar
1 Daly A and Craig S (2016) Activities of Irish psychiatric units and 
hospitals 2015. Dublin: Health Research Board. http://www.
drugsandalcohol.ie/25844/
Trends in alcohol and 
drug admissions to 
psychiatric facilities
Data from Activities of Irish psychiatric units and hospitals 
2015, the annual report published by the Mental Health 
Information Systems Unit of the Health Research Board, have 
shown that the total number of first admissions to inpatient 
care for persons with an alcohol disorder has continued to fall.1
In 2015, 1188 cases with an alcohol disorder were admitted  
to psychiatric facilities, of whom 437 were treated for the 
first time. Figure 1 presents the rates of first admission 
between 1995 and 2015. Trends observed since 1995 have 
continued, with a reduction in the rate of first admissions 
in 2015 compared to 2014. Just over 33% of all cases 
hospitalised for an alcohol disorder in 2015 stayed just  
under one week, while 28% of cases were hospitalised for 
between one and three months.
However, trends of first admissions for alcohol disorders 
contrast with those observed for patients with a drug disorder. 
Figure 2 presents the rates of first admission between 1995 
and 2015 for drug disorder cases. In 2015, 1032 persons were 
admitted to psychiatric facilities with a drug disorder. Of these 
cases, 448 were treated for the first time, which represents 
Figure 1: Rates of psychiatric first admission of cases with an alcohol disorder diagnosis per 100 000 of population in Ireland, 1995–2015
Source: Daly and Craig, 2016
Figure 2: Rates of psychiatric first admission of cases with a drug disorder diagnosis per 100 000 of population in Ireland, 1995–2015
Source: Daly and Craig, 2016
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Programmes could educate parents on the importance 
of spending ‘quality time’ with their children and support 
them in improving their skills for communicating with 
their children.
• They should teach authoritative parenting styles and 
parental monitoring, ensuring participants have the skills 
to implement these at home.
• They should provide parents with the skills necessary 
to deal with the discovery or disclosure of substance 
use. These skills should include understanding effective 
discipline methods and dealing with any conflicts that 
might arise.
• They should generally take account of gender differences 
and the role they might play in parents’ ways of 
communicating with young people and dealing with any 
substance use that may occur. The authors identified a 
particular need to work with fathers.
• They should educate parents about the effects of parental 
substance use on their children, while also targeting young 
people whose parents were substance users with a school-
based programme. (Perceptions of the effects of parental 
substance use on their children were divided; in some 
cases, it was perceived to have a protective effect, while in 
others it increased the risk of use.)
The authors concluded that parenting programmes have 
a role to play in supporting families to develop the skills 
necessary to protect their young people from harm 
associated with substance use.
Lucy Dillon
1 McLaughlin A, Campbell A and McColgan M (2016) Adolescent 
substance use in the context of the family: a qualitative study of 
young people’s views on parent–child attachments, parenting 
style and parental substance use. Substance Use & Misuse, 51 
(14): 1846–1855. http://www.drugsandalcohol.ie/26088/
Young people’s  
views of substance 
use and parenting 
The findings of a qualitative study that sets out to explore 
young people’s perceptions of the mechanisms by 
which family processes protect or place youth at risk of 
substance use have been published. McLaughlin et al.’s1 
work was carried out with a view to informing family-
based interventions preventing drug use. They held nine 
focus groups with a total sample of 62 participants aged 
between 13 and 17 years of age. Participants were post-
primary school pupils from across Northern Ireland. 
While schools were selected from areas with a range of 
multiple deprivation measure rankings, data were not 
collected on individual pupil’s socioeconomic status or 
personal experience of substance misuse. Therefore, the 
findings were based on hypothetical situations rather than 
participants’ personal experiences. This limitation was 
explicitly acknowledged by the authors. Nonetheless, the 
findings included some useful insights that can be used to 
inform intervention development. 
The authors identified three main themes in their analysis 
of young people’s views of how family processes can 
protect or increase the risk of engaging in drug use: 
parent–child attachment; parenting style; and, parent and 
sibling substance use. In their discussion, McLaughlin et al. 
identified a number of messages for parenting interventions. 
These include:
• Parenting programmes should emphasise ways to 
support positive attachments between parent and child. 
to produce crime statistics, it was considered pertinent 
to appraise the data received by the CSO to establish how 
accurate they were.3 Although publication of crime statistics 
restarted following this review, the CSO decided that the 
data would need to be monitored on a regular basis. The aim 
of the second review was to determine whether issues raised 
in the first review still existed. 
This analysis essentially retains the same methodology as 
the previous study.3 However, there are two exceptions: 
sample sizes have been adjusted and the reclassification 
section involves a more detailed analysis. Access was 
provided by An Garda Síochána to crime and non-crime 
data including CAD (command-aided dispatch), paper 
records and non-crime PULSE incident groups, incident 
narrative audit trails, and reclassified incidents. A random 
selection of CAD and paper records was checked against 
corresponding records on PULSE. 
Non-recording of crimes 
In 2015, validated data for crimes (e.g. assault, burglary, 
criminal damage, public order, robbery, theft) that occurred 
in Dublin and in non-Dublin areas reported on CADs were not 
reported on PULSE, 17% and 18% respectively. 
Second review of 
quality of crime 
statistics by CSO
In September 2016, the Central Statistics Office (CSO) 
published its second review on the accuracy of data collated 
on An Garda Síochána’s PULSE (police using leading systems 
effectively) system.1 The initial comprehensive review, 
published in 2015, was centred on data from 2011.
In Ireland, recorded crime statistics provide vital information 
regarding the frequency and type of crime that arises. 
However, in 2014, the Garda Inspectorate raised serious 
concerns regarding how crime was recorded on PULSE.2 
Issues included the non-recording of crimes, lack of 
timeliness in recording crimes, misclassifying crime incidents 
and non-crime incidents at initial stages, alterations of 
narratives, incorrect reclassification of incidents, and 
incorrect application of detection and invalidation status 
to certain crimes. Seeing that the CSO avails of PULSE data 
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In addition, the proportion of validated paper records (16%) 
not reported on PULSE were similar to the 2011 analysis. 
Matching records was challenging; hence, the authors advised 
caution when interpreting results as some records believed 
not to be on PULSE may in fact be within the system. 
Lack of timeliness in recording crimes 
Within the PULSE system a creation date and report date 
are recorded. In 2015, the CSO found that following a crime 
being reported, there was a delay of over one week before 
6% of incidents were recorded on PULSE. Between crime 
categories, the delay ranged from a low of 1% (robbery, 
extortion and hijacking offences; burglary and related 
offences) to a high of 46% of offences against government, 
justice procedures, and organisation of crime.
Alteration of narratives 
The narrative field on PULSE, which records details of a 
crime, can be amended as further information becomes 
available. To determine whether narratives had been edited 
to justify classification decisions, the narrative lengths of 
a random sample of PULSE incident records (n=995) were 
analysed to see if any reductions in length had taken place 
in 2015, which would indicate unacceptable editing. Four 
cases were identified, which was only slightly higher than the 
analysis in the previous report (n=1). 
Misclassification of incidents 
There are approximately 300 crime classifications on PULSE. 
Although the majority are crimes, non-crime classifications 
also exist (e.g. attention and complaints). How crimes are 
classified is essential for accurate reporting. Similar to the 
previous analysis, the CSO focused on six classifications 
of serious crimes – assault minor; assault causing harm; 
criminal damages (not arson); theft from person; burglary; 
and robbery from the person. The analysis indicated that 3% 
of records were classified incorrectly and the classification 
of a further 2% was unclear.
To determine whether non-crime incidents should have 
been classified as crimes, narratives from attention and 
complaints (n=1200), property lost (n=500) and domestic 
dispute (n=300) were examined. Although the majority 
of records were classified correctly (95%–98%), a small 
number of records were either misclassified (1%–3%) or 
unclear (1%–2%). Further analysis indicated that 35 records 
from attention and complaints should have been classified 
as assaults or fraud/public order offences and one each in 
child pornography and robbery; two property lost should 
have been in thefts; and six domestic disputes should have 
been in assaults or harassment. Nonetheless, the percentage 
misclassified had decreased since the 2011 analysis.
Incorrect reclassification of crime incidents
In order to carry out a more in-depth analysis, the CSO 
obtained audit trails for all crimes that had been reclassified 
by An Garda Síochána in 2015 (n=3500). From these audit 
trails, four areas were examined: assault causing harm and 
assault minor (n=233), criminal damage (n=224), arson (n=52), 
robbery from person or institution (n=28) and burglary 
(n=272). The analysis indicated that 68% of reclassifications 
were justified, while 32% were not. Reclassifications were 
upwards (more serious) or downwards (less serious), 24% 
and 48% respectively. Within crime classifications, a higher 
percentage of upward reclassifications occurred in the 
assault minor category (69%). The highest percentage of 
downward reclassifications occurred in the burglary (90%), 
arson (87%), assault causing harm (70%) and robbery from 
person/institution (61%) categories. 
A further analysis of ‘downgrades’ in the burglary category 
indicated that 55% were justified and 45% were not. 
Primarily, unjustified downgrades in this category were for 
reclassifications for attempted burglary to trespassing or 
criminal damage categories. Similarly, in the robbery from 
person/institution category, 59% were justified and 45% 
were not. 
In relation to crimes reclassified into non-crime categories, 
for example 6% of reclassifications in 2015 were to attention 
and complaints, which was lower than the estimate for 2011 
(17%). However, the CSO advises caution when interpreting 
this result as the samples and methodology may not be 
comparable. Notably, three groups – Group 03 Attempts/
threats to murder, assaults, harassments and related 
offences; Group 10 Controlled drug offences; and Group 12 
Damage to property and to the environment – accounted 
for the highest level of reclassifications to attention and 
complaints (11%).
Incorrect application of detection status 
To determine whether ‘detected’ crimes resulted in criminal 
proceedings, 112 879 ‘detected’ crimes were examined. 
Sixty-three per cent, which illustrated an increase since 
2011 (54%), were linked to a charge or summons, whereas 
37% were not. However, the CSO advises caution when 
interpreting this, as the 2011 and 2015 data may not be 
comparable. A further analysis of the accuracy of ‘detection 
rules’ on ‘detected’ crimes with no charge or summons 
(n=1000) indicated that nearly one-fifth of crimes were 
wrongly assigned ‘detected’ (18%), which was nearly half 
of those ‘detected’. This accounted for a 10% (12 789) 
reduction in the total number of ‘detected’ crimes.
Incorrect application of invalidation status 
Invalidation occurred when there was no crime or when 
‘counting rules’ were wrongly applied (p. 28). Out of a sample 
of 1000 invalidated records in 2015, 21% were unjustified, 
which was slightly lower than 2011 (23%). Importantly, an 
unjustified invalidation does not mean a crime has not been 
dealt with correctly; often when a new case is created on 
PULSE, a previous crime linked to the same case becomes 
invalid due to lack of information.
Conclusions and recommendations
The CSO estimated the approximate impact of the problems 
identified in their review. The largest percentage changes in 
2015 were: 
• Group 13 Public order and other social code  
offences (50%)
• Group 03 Attempts, threats to murder, assaults, 
harassments and related offences (33%) 
• Group 12 Damage to property and to the  
environment (32%)
• Group 11 Weapons and explosives offences (31%)
Second review of quality of 
crime statistics by CSO continued
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• Narratives on PULSE need to be more detailed such 
that information recorded supports crime classification 
applied and any subsequent invalidation/detection 
decisions that are made. 
• To overcome quality issues that were delineated in this 
report, it is recommended that An Garda Síochána 
should put structures in place to ensure that crime-
related data are monitored and controlled. 
With the aim of increasing the reliability of the data, the 
CSO continues to collaborate with An Garda Síochána. 
Additionally, the CSO intends to continue monitoring  
the quality of the data by repeating this analysis on an 
ongoing basis.
Ciara H Guiney
1 Central Statistics Office (2016) Review of the quality of crime 
statistics 2016. Cork: Central Statistics Office. Available online at: 
http://www.drugsandalcohol.ie/26176/ 
2 Garda Inspectorate (2014) Report of the Garda Síochána 
Inspectorate: crime investigation. Dublin: Garda Inspectorate. 
Available online at: http://www.drugsandalcohol.ie/22967/
3 Central Statistics Office (2015) Review of the quality of crime 
statistics. Dublin: Government of Ireland. Available online at: 
http://www.drugsandalcohol.ie/24887/ 
Alterations owing to misclassifications within groups were not 
considered; for example, assault causing harm and assault 
minor are both in Group 03.
Consistent with the Garda Inspectorate report and the 
previous analysis in 2011, the analysis carried out by the 
CSO on 2015 data illustrates that discrepancies between 
crimes recorded on CAD/paper and PULSE are ongoing. 
However, although there is evidence of non-recording of 
crimes on PULSE, it has to be acknowledged that crime 
misclassification on PULSE and inaccurate use of detection 
status has reduced since the previous report. 
The CSO made a number of recommendations to further 
improve the quality of crime data. 
• An area that requires immediate attention is the  
CAD narrative field, which should contain all necessary 
information about crimes prior to being closed,  
including a PULSE identity number (ID), and reasons  
for non-recording.
• RC1 forms need to be utilised in all non-CAD divisions.
• It is vital that Garda stations without an electronic 
recording system maintain proper paper records, 
including all crime information along with its associated 
PULSE record.
Case management: models and roles 
Vanderplasschen et al. identified six basic models following 
their review of the case management literature up to 2003.2 
These are outlined briefly below. 
• The brokerage model: Case managers act as ‘brokers’, 
assisting clients to identify their needs and gain access to 
other services or supports; generally, it involves a brief 
engagement with clients with only one or two meetings.
• Generalist models: Case managers work with clients to 
identify needs and negotiate access to required services 
and supports; a longer-term and closer relationship with 
clients is developed over time.
RESPONSES 
HRB drug and alcohol 
evidence review on 
case management
The objective of the HRB’s recently published scoping 
review1 was to examine the peer-reviewed non-experimental 
literature on case management and substance use published 
between 2003 and 2013, and to answer specific research 
questions based on the literature. These comprised 
questions on the nature of case management, the outcomes 
studied, and gaps in the literature.
In a case management approach to service provision, 
clients are typically offered and receive, or are linked to, a 
range of services tailored to meet their specific, individual 
needs. The objective of linking clients to relevant medical 
and social services is a key characteristic of this approach. 
Case managers also frequently work as advocates for their 
clients. This advocacy work may involve liaising with housing 
associations to address accommodation needs or job 
centres to improve employability. The rationale behind the 
linkage and advocacy work is that clients frequently present 
with multiple needs or complications which impact on their 
recovery or rehabilitation. Developing and maintaining links 
with existing services can help to address these multiple 
needs and aid the recovery process. Case management is 
also used to increase client retention in services and improve 
treatment outcomes.
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17 the gaps in the research literature. It is hoped that the report 
can be used by policy-makers and practitioners in Ireland to 
update their understanding and use of case management as 
an approach to improving service coordination and recovery. 
In order to focus this review, three research questions were 
agreed at the outset:
1.  What additional knowledge regarding the nature of case 
management can be gained from a review of recent non-
experimental research on the topic?
2.  What outcomes have been evaluated in the non-
experimental research literature?
3.  What are the gaps in the literature?
What additional knowledge regarding the 
nature of case management can be gained 
from a review of recent non-experimental 
research on the topic?
Case management interventions tend to target 
clients experiencing extreme disadvantage relative 
to other substance misuse treatment clients, with a 
disproportionate amount applying to females. The groups 
of people being targeted by case management present 
with a multitude of personal and social problems, including 
substance misuse, homelessness, economic deprivation and 
mental health problems. 
From the literature reviewed, it would appear that there 
are multiple objectives of case management, including 
reducing substance misuse and visits to hospital emergency 
departments, reducing hospital admissions, and improving 
social and psychological functioning. In addition, there are 
a number of objectives reported in the literature related to 
improving service coordination, such as providing linkages 
with medical and social services and retaining people 
in treatment. The identification of such a broad range 
of objectives points to the multiple needs of the client 
base and the expectations on case management as an 
intervention.
The review identified a number of features of case 
management delivery that were associated with  
improved outcomes reported in the evaluations.  
These included that duration and intensity of the 
intervention could be an important variable to consider 
both in future planning and evaluation of case management. 
Team-based case management and extensive engagement  
by case managers with the client group are also associated 
with positive outcomes. 
What outcomes have been evaluated in the 
non-experimental research literature?
Of the 20 evaluations included in this review, 13 examined 
outcomes under the broad heading of psychosocial 
functioning, which, after substance use, is the second most 
frequent type of indicator in these studies. Two of these 
evaluations – one on a combination of ACT and ICM, and the 
other on using a community-based case management model 
– had a particular focus on quality-of-life issues, and both 
studies showed improvements in these outcome domains. 
Only three of the 20 evaluation studies in the review did 
not find sufficient evidence to support the claim that case 
management contributed to improved outcomes in at least 
one area. The improved outcomes reported in these studies 
may well be associated with the use of case management, 
• Assertive community treatment (ACT): Case managers 
work in teams to help identify client needs and provide 
services directly to clients through assertive outreach.
• Intensive case management (ICM): Case managers 
work on a more intensive, individual basis with clients 
and usually have a lower caseload; they identify needs, 
provide services directly and link clients with relevant 
services.
• The strengths perspective: Case managers seek to 
empower the client to identify their own strengths to 
build on, rather than primarily focusing on correcting 
their deficits; this approach encourages the use of 
informal sources of support and help.
• Clinical case management: Case managers provide direct 
clinical input to clients and combine that with assistance 
in accessing other resources, particularly from the health 
and social care sector.
In recent years, the role of case management has been 
promoted in a number of important policy reports in Ireland, 
which include plans to improve service coordination for 
people in recovery from substance misuse. In 2007, the 
Report of the Working Group on Drugs Rehabilitation3 
made a number of key recommendations and set out the 
structural arrangements required to implement them. One 
of these was the development of broad national protocols 
to facilitate interagency working; these cover issues such 
as confidentiality, common assessment tools, referral 
procedures, and conflict resolution between agencies. 
In 2010, the Health Service Executive (HSE) published the 
National Drugs Rehabilitation Framework (NDRF), setting out 
how services to current and former drug users were to be 
provided in the form of supported integrated care pathways 
(ICPs) with the cooperation of different service providers. 
The report recognised that service users may present with 
diverse needs, such as treatment, education, vocational 
training, employment support and accommodation, and 
that no single agency can cater for all possible needs. 
An individual care plan for each service user needs to be 
delivered by a multidisciplinary team. Where a service user 
has complex and multifaceted needs, a more intensive case 
management approach may be used. The framework stated 
that the provision of rehabilitation pathways is a shared 
responsibility of the education, training and employment 
sectors alongside the health, welfare and housing sector, 
non-governmental organisations, communities, families, and 
the individual themselves. 
The ICP comprises four steps, linked to the four-tier model 
of service provision: initial contact, involving screening and 
referral; initial assessment and identification of appropriate 
service; comprehensive assessment, following which a case 
manager is identified to support the individual on their 
rehabilitation pathway; and implementation of the care plan. 
The HRB’s scoping review was commissioned to examine the 
non-experimental research literature on case management 
and people in recovery from substance misuse. The 
objectives of the review were to explore the nature of case 
management as reported in the literature, document the 
outcomes associated with case management, and identify 
Review on case management 
continued
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A recent review in 2014 by Jackson et al.4 provides a 
useful example on how the realist approach may elucidate 
important learning about case management in future 
investigations.4 This is a realist review and the methods 
used enabled the authors to draw certain conclusions 
about why an intervention may work sometimes and under 
what conditions. Its exploration of the literature in the area 
suggests that engagement with an intervention appears to be 
key to its success. 
It could well be hypothesised that engagement is also a 
key mechanism that is associated with improved outcomes 
in clients of case management, for example, when the 
intervention is intensive, of longer duration, accompanied by 
a good working alliance between the case manager and client 
and with dedicated care plans. These components could 
well contribute to the client engaging with the intervention 
and ‘investing’ in their recovery and accruing some benefits. 
Further evaluation and synthesis of case management with 
people in recovery from substance misuse are needed 
to investigate the role of these potential features of case 
management in delivering improved outcomes for clients. 
Brian Galvin
1 Nic Gabhainn S, D’Eath M, Keane M and Sixsmith JA (2016) 
Scoping review of case management in the treatment  
of drug and alcohol misuse, 2003–2013. HRB Drug and  
Alcohol Evidence Review 3. Dublin: Health Research Board. 
http://www.drugsandalcohol.ie/26681/
2 Vanderplasschen W, Wolf J, Rapp RC and Broekaert E (2007) 
Effectiveness of different models of case management for 
substance-abusing populations. Journal of Psychoactive Drugs, 
39(1): 81–95.
3 Working Group on Drugs Rehabilitation (2007) National  
Drugs Strategy 2001–2008: rehabilitation. Report of the  
Working Group on Drugs Rehabilitation, May 2007. Dublin: 
Department of Community, Rural and Gaeltacht Affairs.  
http://www.drugsandalcohol.ie/6267/
4 Jackson LA, Buxton JA, Dingwell J, Dykeman M, Gahagan J, 
Gallant K, Karabanow J, Kirkland S, LeVangie D, Sketris I, Gossop 
M and Davison C (2014) Improving psychosocial health and 
employment outcomes for individuals receiving methadone 
treatment: a realist synthesis of what makes interventions work. 
BMC Psychology, 2(1): 26.
or they may be due to unknown factors or influences which 
cannot be ruled out given the design of the evaluations 
reported. Only one-quarter of the evaluation studies used 
a comparison group; the rest of the evaluation studies used 
retrospective single groups and before-and-after designs.
What are the gaps in the literature?
Vanderplasschen et al. argue that there is a need to consider 
outcomes beyond drug use and other ‘socially acceptable 
outcomes’ and to take into account quality-of-life outcomes 
and clients’ subjective perceptions when evaluating the 
effectiveness of case management. They also noted that 
there is little information on the crucial features of case 
management and what specific aspects of this intervention 
contribute to specific outcomes. This is exacerbated by the 
lack of fidelity in implementation and the distance between 
the model chosen and its practical application. 
The review identified similar gaps in the literature as those 
reported by Vanderplasschen et al. As pointed out above, 
in the 20 evaluations included in this review, two broad 
categories of outcomes were evaluated. The predominant 
use of these hard outcomes to evaluate case management 
suggests an overemphasis on using case management as 
a deficit-reduction intervention. Indeed, there is almost a 
complete absence in the literature of the strengths-based 
case management model being used and evaluated. This type 
of model prioritises the empowerment of the client group by 
emphasising their strengths and would be more amenable to 
evaluating the softer outcomes that may be associated with 
improvements in quality of life. 
This review also identified a major gap in the literature 
around any attempt to identify what specific aspects of 
case management contribute to improved outcomes. In 
essence, both primary and secondary studies sought to 
determine whether case management works for people in 
recovery from substance misuse; in the main these studies 
and reviews have produced some evidence to suggest 
that case management is an effective intervention to 
use with this target group. While such study designs are 
important in determining the efficacy and effectiveness of 
an intervention, the authors suggest that the evidence base 
would also benefit from an evaluation approach that seeks to 
understand not only does it work, but for whom and under 
what conditions and contexts. They suggest that the realist 
approach to evaluation and synthesis may be an appropriate 
approach to consider for researchers and reviewers to use in 
future investigations of case management. 
The authors suggested earlier that certain features of case 
management identified in this review – notably the duration, 
intensity, the team-based nature of some of the work and 
the nature of the engagement between case managers and 
clients – could be important variables that require further 
elaboration and evaluation. Although their observations are 
based on a small number of studies, the authors reiterate 
the point here and suggest that these features and perhaps 
many more could be investigated using the realist approach. 
The realist approach is a theory-driven approach to 
evaluation and synthesis; it seeks to uncover the processes 
or mechanisms that lead to particular outcomes, and the 
context within which this occurs. 
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17 Launch of the 
Evaluation of the 
HSE Naloxone 
Demonstration 
Project
On 30 August 2016, Minister of State for Communities and 
National Drugs Strategy Catherine Byrne TD attended the 
launch of the Evaluation of the HSE Naloxone Demonstration 
Project in Temple Bar, Dublin.1 The external evaluation was 
commissioned by the HSE National Social Inclusion Office 
and its launch coincided with International Overdose Day. 
The key theme was ‘Time to Remember, Time to Act’, which 
acknowledged the trauma and suffering of families and friends 
affected by drug misuse. The aim of the day was to reduce the 
stigma of drug-related deaths and to spread the message that 
overdose death and injury is preventable.
Background
In Europe, between 6000 and 8000 deaths by overdose are 
reported annually with the majority as a result of heroin or 
opiate overdose.2 In Ireland, based on figures reported in the 
National Drug-Related Deaths Index (NDRDI) for 2013, opioids 
were implicated in 203 deaths, representing 58.2% of the total 
number of poisonings that year.3 A principle finding in this data 
was that 42% of these individuals were not alone at the time 
of death. This indicated that an appropriate intervention, such 
as the administration of an opioid reversal agent like naloxone, 
could have potentially saved those lives. 
Naloxone is a semi-synthetic drug used to temporarily 
alleviate the physiological symptoms of opiate overdose. It is 
listed by the World Health Organization as a specific antidote 
and was included on the Model list of essential medicines 
in 2013.4 Administered intravenously, intramuscularly or by 
nasal spray, naloxone temporarily reverses the respiratory 
depression experienced during an overdose, providing a life-
saving period before emergency services arrive for further 
medical intervention.
Naloxone Demonstration Project
Under Action 40 of the current National Drugs Strategy and 
addressing the four tiers of the Rehabilitation Pathway of the 
National Drugs Rehabilitation Implementation Committee 
(NDRIC),5,6 the purpose of the HSE Naloxone Demonstration 
Project was to test the feasibility of making naloxone 
available to prevent death from overdose. The first part of 
the project involved formal briefing and training of drug 
users and those close to them (including service providers, 
front-line workers, family members, and friends) on how to 
use naloxone and how to recognise and manage overdose 
events. The second part involved prescribing naloxone kits 
to 600 opioid users in Dublin, Limerick, Cork and Waterford 
following training. The naloxone kits were single, individual 
use prepacked syringes containing five doses of Prenoxad® 
(1 mg/ml injection). Intramuscular administration of naloxone 
was used as no intranasal device has yet been approved for 
the European market. 
Over a two-year preparatory period, a quality advisory group 
(QAG) was established to oversee the implementation of the 
project and extensive input was sought from a number of 
different stakeholders.7 A cascade-style training model for the 
project was agreed and comprehensive training materials and 
resources were developed. The project formally commenced in 
February 2015 and the external evaluation began in June 2015, 
involving action research which continued until October 2015. 
A process evaluation was carried out to analyse the content 
and quality of the training programme, and to gather feedback 
from training participants. In addition, an outcome evaluation 
of the training was conducted, and the effect of the practical 
application of naloxone and harm-minimising techniques to 
reduce the number of fatal overdoses was investigated.
An open invitation was sent to all relevant services to take 
part in the naloxone and overdose training alongside the 
implementation of a programme to increase awareness of the 
project in potentially interested stakeholders, e.g. homeless 
services, National Family Support Network (NFSN). Thirty-one 
people took part in a train-the-trainer programme, one-third 
of whom cascaded the training programme across the four 
demonstration sites. By October 2015, close to 600 people 
had received the naloxone and overdose training, comprising 
a diverse group of general practitioners (GPs), pharmacists, 
front-line workers, HSE and Irish Prison Service personnel, 
opioid users, family members and outreach workers. 
Attending the launch of the Evaluation of 
the HSE Naloxone Demonstration Project, 
Mr Tim Bingham and Minister of State 
for Communities and the National Drugs 
Strategy, Catherine Byrne TD
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Results of evaluation
Each participant completed a survey before and after 
the training. The results revealed significantly increased 
understanding and awareness of how to recognise and manage 
an opioid overdose event and the steps taken to administer 
naloxone appropriately. In total, 95 naloxone prescriptions 
were issued during the project by six GPs; the majority (67%) 
of prescriptions were in Dublin and the remainder (33%) in 
Limerick. As the project ended, another GP began prescribing 
naloxone in Waterford, as did the Drug Treatment Programme 
in the Irish Prison Service at Mountjoy Prison, Dublin. There 
were five separate overdoses during the project and in each 
case naloxone was administered in accordance with the 
predefined procedure. Four of these administrations were 
carried out by a front-line worker and the fifth was peer-to-
peer. Notably, each naloxone kit was administered to a person 
other than for whom it had been prescribed. The evaluation 
found that the project successfully minimised the number of 
potentially fatal overdoses in Ireland between February and 
October 20158 and concluded that widespread accessibility 
and availability of naloxone was crucial to its life-saving 
function in the community. 
Post-overdose event interviews were conducted, which showed 
that those who administered the naloxone felt pride and relief in 
their contribution to saving a life. Being armed with a tool to use 
in the event of an overdose situation provided these individuals 
with increased confidence and a sense of empowerment. 
Although four demonstration sites were initially included in the 
project, no prescriptions were issued in Cork. The factors which 
improved uptake in the other demonstration sites were listed as 
increased prior knowledge of and interaction with the project; 
availability of local champions; belief in the efficacy of naloxone; 
clear communication of the process and referral pathways; 
acceptance, willingness and availability of GPs locally to engage 
and prescribe naloxone from the outset; and support from the 
NFSN and its membership on the ground.
Recommendations
The evaluation recommended the national implementation of 
the demonstration project in a managed, phased and strategic 
manner. This process will demand intense logistical coordination 
and specific areas of the project will require revision and 
reworking. The evaluation provided six key recommendations 
centred on ‘communication, consultation, training design, 
robust research and planning for future roll out and distribution 
of naloxone in Ireland’ (p. 57).1
1 Improved communication is required on a national level. 
Feedback should be given adequate consideration in 
advance of an all-Ireland rollout of the scheme. 
2  The governance of the QAG should be strengthened and 
membership extended to include clinical expertise and 
regional representation. 
3  Naloxone should be rolled out in Ireland in a measured, 
phased and strategic manner with a focus primarily on the 
Waterford/South East and Cork region. Dedicated staff and 
resources should be assigned to coordinate this process 
efficiently. 
4  The training programme should be accredited by an 
appropriate body and should incorporate the learning 
from the evaluation. In addition, the programme should 
be flexible and constantly evolving to incorporate future 
feedback from participants, changes in legislation and 
product availability. 
5 The briefing of opioid users, family members, friends 
and front-line workers should be continually monitored 
carefully and supported. In particular, the opioid users 
receiving the naloxone prescriptions should be given 
special attention, where health, well-being and drug-
related behaviour are tracked over time.
6  Multidisciplinary research with a focus on clinical 
governance should take place relating to naloxone in 
Ireland. This research should be overseen by the QAG.
 
In terms of health economics, the project represented 
a good return on investment (€62,500) for the HSE. The 
demonstration project was responsible for the widespread 
training of opioid users, service providers and a wide range 
of other organisations about the threat of overdose and the 
potential of naloxone to save lives. 
It has removed some of the stigma associated with drug 
misuse and provided people with a powerful life-saving,  
harm-minimising tool for use in overdose situations.
The evaluation highlighted the positive effects of naloxone as a 
‘catalyst for positive change in behaviour in drug use and harm 
minimisation’ (p. 52). The authors felt that the demonstration 
project was well received in Ireland among the family members 
and front-line workers, and was deemed a success. In addition, 
given the approval of an intranasal formulation of naloxone by 
the US Food and Drug Administration in 2015, it is possible that 
the use of this device may be incorporated into new legislation 
in Ireland once a European equivalent becomes available. 
Thérése Lynn
1 Clarke A and Eustace A (2016) External evaluation of the HSE 
Naloxone Demonstration Project. Dublin: Health Service Executive 
(HSE). http://www.drugsandalcohol.ie/26037/
2 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
(2015) European Drug Report 2015: trends and developments. 
Luxembourg: Publications Office of the European Union.  
http://www.drugsandalcohol.ie/24029/
3 Health Research Board (2015) Drug-related deaths and deaths 
among drug users in Ireland: 2013 figures from the National Drug-
Related Deaths Index. Dublin: Health Research Board.  
http://www.drugsandalcohol.ie/24676/
4 World Health Organization (WHO) (2013) WHO model list of essential 
medicines. 18th edn. http://www.who.int/medicines/publications/
essentialmedicines/en/
5 Department of Community, Rural and Gaeltacht Affairs (2009) 
National Drugs Strategy (interim) 2009–2016. Dublin: Department of 
Community, Rural and Gaeltacht Affairs. http://www.drugsandalcohol.
ie/12388/
6 Department of Community, Rural and Gaeltacht Affairs (2007) National 
Drugs Strategy 2001–2008: rehabilitation. Dublin: Department of 
Community, Rural and Gaeltacht Affairs. http://www.drugsandalcohol.
ie/6267/
7 Consultation took place with ‘key stakeholders within the Department 
of Health, Health Products Regulatory Authority (HPRA), National 
Family Support Network (NFSN), voluntary support network, Irish 
Prison Service (IPS), Ana Liffey Drug Project (ALDP), Merchants Quay 
Ireland (MQI), National Drugs Rehabilitation Implementation Committee 
(NDRIC), SafetyNet, Primary Care, Pre-Hospital Emergency Care 
Council (PHECC) and the HSE Addiction Services’. (p. 27).
8 A further three overdose events and naloxone administrations 
occurred between November 2015 and January 2016.
HSE Naloxone  
Demonstration Project continued
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17 New psychoactive 
substances in Europe 
conference, Poznan
On 26–27 October 2016, the Polish Reitox Focal Point and 
National Bureau for Drug Prevention held a conference on 
new psychoactive substances (NPS) in Europe. The conference 
opened with an overview of EMCDDA and the EU Early Warning 
System (EWS), which monitors and responds to new drugs 
or trends in drug use. Information is fed into the EU EWS by 
national focal points; this information exchange can trigger 
the preparation of joint reports and a formal risk assessment 
process followed by control measures as required. 
There have been over 600 NPS notified to the EMCDDA and, 
of these, approximately two-thirds have been notified since 
2012. The biggest group of NPS is synthetic cannabinoids 
followed by cathinones. Synthetic benzodiazepines and 
synthetic opioids have recently emerged, including extremely 
potent synthetic fentanyls. There is no sign of a decrease in 
this flow of new drugs with 98 new psychoactive substances 
reported in 2015. While approximately 250 of these drugs are 
internationally controlled, the rest are not. 
‘Chasing the white rabbit’
The analogy ‘chasing the white rabbit’ described a common 
theme throughout many presentations, namely, legislation 
introduced to ban NPS has driven the production of 
new substances, some worse than the originally banned 
substances. While ‘brick and mortar’ shops selling NPS have 
been largely eliminated, the market has simply moved online. 
Chinese manufacturers of NPS are reportedly capable of 
creating any drug upon request, including providing the 
precursor if desired, packaging and describing the product 
in any way requested, and advising on additional protective 
measures and new ways to transport. 
The 2016 EU drug markets report states that:
Globalised supply chains and the internet play 
a major role in driving the availability of new 
substances in Europe. Underpinning this growth is 
the ability to order bulk quantities of new substances 
from companies in China and to transport them 
rapidly to Europe by air or sea. Actors in the EU then 
package and market them either on the open market 
or directly on the illicit drug market.1
The near-impossible task of stemming the flow of NPS 
in the current globalised world was highlighted by Polish 
Customs officials, citing the enormous volumes of imports 
annually, extensive borders, increased flights, increased 
shipments, and millions of Customs declarations (often 
impossible to decipher). Misdeclarations are also common. 
The huge variety of NPS drugs and the rapid emergence of 
replacements when substances are banned cause difficulties 
in securing convictions for police across Europe, especially 
since a seizure may, after analysis, prove to be a non-
controlled substance. Sanctions for the production and 
trafficking in NPS available to authorities in Poland include 
financial and administrative as well as penal sanctions.
Risk assessment and safety
At EU level, scientific risk assessment is separated from 
political decision; however; it is not possible to deal with 
the current numbers of NPS through this system and a 
three-stage assessment process is being progressed. The 
use of precautionary-based policies, adopted in a number 
of countries, as opposed to evidence-based policies (risk 
assessment) was discussed, posing the question ‘Are we 
doing the right thing?’
Information about safe doses and risks associated with 
NPS should be provided to NPS users as a harm reduction 
measure. Also, medical staff need to be better informed 
so they can best treat emergencies. The EMCDDA 
recommended the development of hospital emergencies 
data as an instrument to be included in routine reporting.2 
In Poland, medical staff are required to report all NPS 
intoxications centrally, and this information is submitted 
to the Ministry of Health. Collated data can quickly alert 
authorities to dangers, such as the introduction of a new 
substance on the market. The health indicator monitored in 
Poland is medical interventions per 100 000, which reached 
7284 in 2015, including 1627 in the 16–18 years age group and 
2817 in the 19–24 years age group. The highest users of NPS 
are 19–24-year-olds (who were initially exposed to these 
substances as teenagers from 2008 onwards). 
Peaks in intoxications occurred prior to planned legislative 
changes, when suppliers offered sales and promotions 
on products about to be banned. Suppliers immediately 
responded to bans with a range of new substances and 
promotions, such as offering free samples as ‘testers’. In 
Poland, deaths attributed to NPS increased from 3 in 2013 to 
22 in 2015. In Estonia, the main problem drugs are fentanyls 
(in Talinn) and amphetamines (in Narva). Drug-related deaths 
in Estonia decreased from 170 in 2012 to 88 in 2015. This is 
attributed to the naloxone programme introduced in 2013; 
1336 personnel have been trained in the use of naloxone to 
treat opioid overdose, including 1054 drug users.
Research and information gathering
The need for better ways to monitor and gain insight and 
understanding of NPS users was advocated throughout 
the conference. This is regarded as essential in order to 
elucidate the attraction of these drugs and thereby help 
prevent social harm. Different aspects of information 
gathered by the I-TREND project carried out in several 
European countries were described.3 This multifaceted 
project included:  
• Automated analysis of online shops using a prototype 
software acting as a ‘robot’ trawling forums4
• Purchase and analysis of NPS online (The most reliable 
sources for online purchase were in the UK.)
• Survey of online users to identify motivations of NPS 
users and circumstances of use
• Analysis of national preferences
The survey of online NPS users found 72% were males aged 
15–24 years, most were in education, living in cities and 
polydrug users. The reason(s) for taking these drugs included 
to socialise (53%), get high (51%), modify perception (47.5%), 
relax (32.5%), and personal curiosity (44.5%). 
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methods, investigation of fast screening with handheld 
device and electronic repository of nitrogen/phosphorus 
detector data. 
A challenge in compiling and sharing data is that chemical 
data are formatted differently in various databases with 
a wide range of vendor-specific formats for each drug, 
proprietary spectra formats, and complex data streams. 
There is also a need for a unique way to unambiguously 
name compounds, as current systematic chemical naming 
protocols can give several variants to the same molecule.
Siobhan Stokes
1 European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) (2016) EU drug markets report. Luxembourg: 
Publications Office of the European Union. http://www.
drugsandalcohol.ie/25357/
2 EMCDDA (2016) 2016–18 strategy and work programme and 2016 
annual work programme. Available online at http://www.emcdda.
europa.eu/publications/work-programmes-and-strategies/2016-
work-programme 
3 For more information on I-TREND, visit http://www.i-trend.eu/
4 Open source software is available online at https://github.com/I-
TREND/SASF 
5 European Commission (2016) Fostering the detection of 
‘legal highs’. Available online at https://ec.europa.eu/jrc/en/
news/fostering-detection-legal-highs; Systematic analytical 
characterization of new psychoactive substances: a case study. 
Available online at https://ec.europa.eu/jrc/en/publication/
systematic-analytical-characterization-new-psychoactive-
substances-case-study
Further research was presented based on analysis of  
1 281 660 posts from internet forums identifying the 
motivation of users, the context of NPS use (where used 
and with whom), substance trajectories, and characteristics 
of users. NPS users were then categorised as six different 
types: scientist experts; experimenters; kami-kase cyborgs; 
novices; superman; or partygoers.
 
The need for a change of attitude towards drug users  
was also advocated. It was argued that since it will never  
be possible to reduce drug use to zero, rather than 
penalising users, a better approach would be to promote  
a healthy lifestyle in the same way that alcohol and tobacco 
use are addressed.
Collaboration and sharing of analytical 
information
Collaboration and sharing of analytical information  
was the final theme explored. European data-sharing 
initiatives include:
 
• EMCDDA’s European Database on New Drugs (EDND): 
This is under redevelopment to improve information and 
searchability of the database. A pilot will launch in 2017. 
• EU Joint Research Centre Directorate: Cloud 
spectroscopy for identification and monitoring of new 
psychoactive substances aims to provide fast recognition 
of NPS5 and unknown chemicals, harmonised analytical 
Union Players Association (IRUPA) is sponsored by Diageo; 
and Fergus Finlay is a mentor to the Arthur Guinness Fund 
supporting social entrepreneurs. It was not possible to 
ascertain if board members had any links to other alcohol 
companies. The campaign itself was supported by public 
relations firm Goddard Global, which has had both Diageo 
and tobacco companies as clients and is linked to the 
Common Sense Alliance, a tobacco industry lobby group.
Framing the problem
Although the campaign focuses on ‘out of control drinking’, 
what this means is not clearly defined. The authors found 
that the campaign used vague or self-defined concepts of 
‘out of control’ and ‘moderate’ drinking, presenting alcohol 
harm as a behavioural problem rather than a health issue. 
There was no attempt to quantify moderate drinking, while 
one board member described the internationally public 
health measure of binge drinking as being ‘unhelpful’. Some 
board members stated that moderate drinking is normal, and 
identified not drinking as abnormal; several also stated that 
critics of the campaign are non-drinkers and prohibitionists. 
In relation to alcohol-related harm, the campaign emphasised 
antisocial behaviour; in contrast, the health harms associated 
with alcohol were almost entirely absent from discussions, 
even though alcohol-related health harm in Ireland is 
considerable. The focus was on young people, particularly 
young women, despite alcohol harms affecting men, women 
and children across the whole population. It was the opinion of 
the board members that the main causes of excessive drinking 
in young people were individual attitudes and motivations; Irish 
culture, tradition and society; and peers and parents. 
Stop Out of Control 
Drinking campaign
The Diageo-funded ‘responsible drinking’ campaign named 
Stop Out of Control Drinking (SOOCD) was launched in 
February 2015 and chaired by Fergus Finlay, the chief 
executive of Barnardos. Since its inception, it has generated 
controversy due to its funding by the alcohol industry, and it 
has been claimed that it is merely a smokescreen to take away 
political focus from reforms in the Public Health (Alcohol) Bill 
2015 around minimum pricing, marketing, alcohol promotion 
and alcohol availability.1 A recent study analysed the SOOCD 
campaign. Its aims were to identify how the campaign and its 
advisory board members frame and define alcohol-related 
harm and its causes, and possible solutions.2 This involved 
undertaking an analysis of SOOCD campaign material, which 
included newspaper articles (n=9), media interviews (n=11), 
Facebook posts (n=92), and Twitter tweets (n=340) produced 
by the campaign and by board members.
SOOCD board members 
Initially, there were 17 board members, although four 
subsequently resigned, including David Smith, Diageo Ireland 
country director. A number of the remaining board members 
or their organisations have links to Diageo/Guinness. Gavin 
Duffy worked as an alcohol industry consultant and for 
Guinness; Sport for Business has Guinness as a client; Dublin 
City University has received Diageo funding; the Irish Rugby 
New psychoactive substances 
conference continued
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17 The authors conclude that the content of the SOOCD 
campaign reflects the needs of the alcohol industry rather 
than public health. They suggest that the main effect of 
the campaign may be to protect the reputation of Diageo 
in Ireland, while undermining the recent Public Health 
(Alcohol) Bill. 
The current status of the campaign is unclear. Initially, it was 
intended to last for five years; however, social media activity 
appears to have ceased, and the SOOCD website is currently 
inaccessible (access attempted 20 October 2016). 
Deirdre Mongan
1 Ó Fátharta C (2015) Third group steps down from Diageo alcohol 
campaign. Irish Examiner 25 Mar 2015. Retrieved 20 October 
2016 from http://www.irishexaminer.com/ireland/third-group-
steps-down-from-diageo-alcohol-campaign-320271.html.
2 Petticrew M, Fitzgerald N, Durand MA, Knai C, Davoren M, Perry I 
(2016) Diageo’s ‘Stop Out of Control Drinking’ campaign in Ireland: 
an analysis. PLoS One, 11(9): e0160379.
 
They also highlighted that it is individuals themselves that are 
responsible for creating the Irish drinking culture, and they 
appeared to absolve the alcohol industry of any responsibility 
towards the creation or maintenance of this culture. In some 
cases, the responsibility of industry is explicitly excluded as an 
influence by board members. 
Framing the solutions to ‘out of control 
drinking’
Similar to the alcohol industry, board members focused on 
dealing with alcohol misuse, particularly in young people, 
rather than looking at alcohol as an issue for the general 
population. Board members generally did not recommend 
evidence-based population-based approaches, such as 
alcohol marketing restrictions, minimum unit pricing, and 
restrictions on availability. Conversely, they placed strong 
emphasis on educational interventions which are widely 
accepted as being ineffective. The need for evidence in dealing 
with the problem of ‘out of control’ drinking is mentioned, 
but scientific evidence is just one aspect to be considered 
alongside views, conversations, stories and experiences.
Stop Out of Control Drinking 
campaign continued
violence and crimes against children will continue to  
be targeted and investigated by An Garda Síochána.  
In order to provide enhanced protection for children,  
tools for risk assessment and risk management frameworks 
will be developed. This will allow Gardaí to identify the  
level of risk to which victims of sexual and domestic  
violence are exposed. 
With the aim of averting and exposing crime, national anti-
crime strategies, such as Operation Thor, will continue to 
play an important role in reducing crime. The investigation 
of crimes will be reinforced by the ongoing development 
and implementation of IT systems, such as the major 
investigations management system (MIMS).
The intention is to make victims of crime the focus of 
policing services, which is in alignment with the EU Directive 
on Victims Rights2 and the Criminal Justice (Rights of Victims) 
Bill.3 The ability to respond and manage incidents will 
therefore be developed by:
• enhancing computer-aided dispatch (CAD) 
• developing strategies in the control room with the aim of 
improving service and contact response rates with the 
public, and
• being more efficient in the capture, collation and review 
of data collected.
Interagency collaboration is viewed as an essential 
component of addressing and managing repeat offending, 
and includes ongoing development of the Garda Juvenile 
Diversion Programme, implementation of the Strategic 
Approach to Offender Recidivism (SAOR) and the Joint 
Agency Response to Crime (J-ARC) initiative.
An Garda Síochána 
Policing Plan 2016
An Garda Síochána Policing Plan 2016 identifies the policing 
commitments for 2016.1 The focus of the plan is to protect 
communities and individuals in Ireland from risk and harm 
connected with crime, drugs, and domestic-related crime 
(e.g. burglaries and domestic violence). A number of areas 
have been identified as priorities for An Garda Síochána in 
2016: national security and intelligence; national policing; 
community safety; and cross-organisation services.
National security and intelligence
The key objective of this priority is to defend the interests of 
Ireland in alleviating threats from terrorists by implementing 
a number of strategies, such as the International Counter-
Terrorism Strategy, Cyber Security Strategy, and the joint 
Cross-Border Policing Strategy. In addition, the development 
of partnerships with policing and security organisations 
in Ireland and oversees will enable An Garda Síochána to 
contribute to worldwide security. Renewed attention will 
be placed on the management of intelligence and will result 
in the establishment of intelligence management systems in 
units nationwide. In preparation and in alignment with the 
framework for major emergency management, a strategy 
will be put forward to ensure that Ireland is ready for major 
emergencies should they arise. A contribution will also be 
made to the National Major Emergency Response Group.
National policing
The overall aim of the Irish policing service is to prevent all 
types of crime, for example organised and cross-border 
crime, which includes human trafficking, prostitution, 
burglary, drug-related crime, white collar crime, and crimes 
against business and agriculture. Domestic and sexual 
23
Issue 60
 | W
inter 20
17      drugnet IR
ELAN
D
      
• Identifying the core functionality of the service in order 
to make bureaucratic processes easier and thus moving 
towards leaner administrative systems.
• Working in partnership with the Garda Inspectorate, 
Garda Síochána Ombudsman Commission (GSOC) and the 
Policing Authority to implement recommendations and 
feedback.
• Addressing effective management of expenditure by 
targeting how financial resources are managed to support 
policing, fleet investment, and tenders for outsourced 
services (e.g. medical, uniforms, construction of two 
facilities for evidence and property).
• Working in partnership with local, national and 
international agencies, including academia and agencies, 
will increase collaboration resulting in stronger 
connections with partner agencies.
 
Although the Policing Plan 2016 outlines numerous changes 
and areas for development, Garda Commissioner Nóirín 
O’Sullivan argues that ‘policing [in this way] will be delivered 
differently with the aim of providing the country with a world 
class police service. But what won’t change is An Garda 
Síochána’s unstinting commitment to protecting communities 
and this State’ (p. 4).
Ciara H Guiney
1 An Garda Síochána (2016) An Garda Síochana Policing Plan 
2016. Available online at http://www.drugsandalcohol.ie/25794/
2 Directive 2012/29/EU of the European Parliament and of the 
Council of 25 October 2012 establishing minimum standards 
on the rights, support and protection of victims of crime, and 
replacing Council Framework Decision 2001/220/JHA. Available 
online at http://eur-lex.europa.eu/legal-content/EN/TXT/
PDF/?uri=CELEX:32012L0029&from=EN
3 The Criminal Justice (Victims of Crime) Bill (unpublished). Relevant 
Dáil debates available online at http://oireachtasdebates.
oireachtas.ie 
4 Garda Inspectorate (2014) Report of the Garda Síochána 
Inspectorate: crime investigation. Dublin: Garda Inspectorate. 
Available online at http://www.drugsandalcohol.ie/22967/ 
Community safety
The Policing Plan 2016 seeks to build on public safety by 
setting out a new community policing framework and a 
new crime prevention strategy. The intention is to avail 
of ‘local policing fora’ and joint policing committees 
(p. 9). Additionally, another priority is to build positive 
partnerships with community groups that may be diverse, 
at risk or difficult to reach. The aim is for Gardaí to be 
more visible within the community, which should result 
in greater detection and prevention of public disorder, 
antisocial behaviour, and illegal consumption of alcohol 
in public places. In order to improve communication, the 
Garda Communications Strategy, which aims to improve 
communication within the organisation, the State and the 
general public, will be implemented. 
Safety on Irish roads is also targeted. Enforcement and 
education are viewed as important contributors to increasing 
safety on roads and within communities. Recommendations 
put forward by the Garda Inspectorate in their report on 
fixed charges will result in greater efficiency and more 
accountability.4 Additionally, it has been proposed to 
implement more automatic number plate recognition (ANPR) 
technology, as this will allow Garda to ‘track and target’ 
offenders (p. 9).
Cross-organisation services
The final objective of the Policing Plan 2016 is to ensure 
that resources used in the delivery of a professional policing 
and security service are effective and efficient. The main 
objectives to be delivered include:
• Optimising the development and deployment of skills 
and human resources across the organisation. This 
will include delivery of a Human Resource and People 
Development Strategy, revising recruitment, selection 
and internal appointment procedures as well as the 
identification and implementation of technology suitable 
for monitoring performance and development.
• Developing strong governance and leadership throughout 
the organisation. The goal is to develop and implement 
a corporate governance framework delineated in 
accordance with best practice. Additionally, other 
initiatives to be applied include standardised approaches 
for the performance and accountability framework (PAF), 
the Garda transformation programme, performance 
management systems, inspection and review processes, 
policy frameworks, and risk management.
• Instilling a culture of continuous improvement via 
education, training, and development. The aim is to 
determine how the core vocational and operational 
training is to be strategically measured and quantified 
with a view to evaluating how they compare with the 
current continuous professional development structures 
already in place.
An Garda Síochána Policing  
Plan 2016 continued
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17 Policy, Social Work and Social Justice – and onsite visits to 
potential venues, the conference bid was successful, and 
awarded to Dublin in March 2016. 
The conference in Dublin is expected to attract around 300 
participants from across Ireland and the globe. It aims to 
build capacity and knowledge among all professionals and 
sectors with a stake in a healthy nightlife, including municipal 
and state policy-makers, public health planners, medical 
and nursing practitioners and scientists, drug and alcohol 
addiction service providers, criminologists, local authorities, 
transport sector and government agencies, representatives 
of the various nightlife industries, and, most importantly, 
citizens and customers using or affected by the night-time 
economy. The European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) is a key partner in the Dublin 
conference and will be presenting aspects of their current 
and relevant research at the event. 
Networking is an important feature of all Club Health 
conferences. Previous conferences have developed and 
enhanced a powerful interdisciplinary international network 
of academics and practitioners, resulting in European and 
international research and practice collaborations with 
further similar alliances expected to emerge from the Dublin 
2017 event. 
Issues and topics
There will be many significant issues and topics explored in 
the conference. These include drug legislation and drug law 
reform; emerging trends in club culture; forensic testing of 
drugs or ‘pill testing’ and ‘early warning systems’; health and 
safety standards for nightlife environments; harm-reduction 
interventions in nightlife settings; NPS; nightlife legislation, 
policy and economic impact of measures such as ‘lock out 
laws’ and night mayors; policing in the nightlife settings and 
in nightlife tourism destinations, such as Dublin’s Temple Bar; 
sexual health and risk-taking sexual behaviours; violence in 
a nightlife context; social exclusion – or nightlife without 
money; and other cutting edge and emerging relevant topics. 
The Club Health Dublin 2017 conference will be held in the 
Printworks in Dublin Castle, 24–26 May. It promises to be 
a stimulating, engaging, diverse and comprehensive event, 
assessing and debating what works to make the nightlife 
environment heathier, economically viable, and safer.  
And all this without losing core focus on the essential  
fun, dynamic and vibrant elements of a good night out.  
The call for abstracts and poster presentations is open via 
the Club Health Dublin website, where registration details 
and further information on the event and how to participate 
can also be found. 
Siobhán O’Brien Green
1 For more information on Club Health 2017, visit  
http://theclubhealthconference.com/ 
2 Department of Health (2015) National Sexual Health Strategy 
2015–2020 and action plan 2015–2016. Dublin: Department of 
Health. http://www.drugsandalcohol.ie/24714/
3 TNS Political & Social (2014) Flash Eurobarometer 401: young 
people and drugs. Luxembourg: European Commission.  
http://www.drugsandalcohol.ie/22196/
Club Health 2017 
conference to be 
held in Dublin 
The 2017 Club Health 
International Conference 
on Nightlife, Substance Use 
and Related Health Issues 
will be held in Dublin Castle 
from 24 to 26 May 2017.1 
This will be the 10th Club 
Health conference and the 
first to be held in Dublin. 
Club Health conferences 
bring together experts from a wide range of fields to meet, 
present and exchange information on the latest research, 
policy and practice on protecting and promoting health 
in urban night-time settings, music festivals and holiday 
destinations with a clubbing or nightlife focus. Professor 
Mark Bellis and Dr Chris Luke, in collaboration with HIT, the 
groundbreaking harm-reduction organisation, established 
Club Health in Liverpool in 1997. This was in response to the 
harm-reduction and health-promotion challenges of that 
city’s night-time economy. The first conference was held in 
the city’s very popular nightclub, Cream, and was prompted 
initially by the health and crime consequences that came 
with this popularity.
Global conference
Club Health has grown since 1997 to become a global 
conference that attracts a diverse range of expert 
international speakers and multidisciplinary participants, 
such as academics, researchers, club owners and clubbers. 
Club Health conferences have been held biennially since 
1997, organised primarily by the Public Health Institute 
in Liverpool John Moores University, in partnership with 
host organisations, government departments and agencies 
in many countries. These include the Netherlands, Italy, 
Australia, Slovenia, Spain, the Czech Republic, Switzerland, 
the USA and, in 2015, Portugal.
Dublin bid
Following the 2015 Lisbon conference, a small group began 
working on a bid for the conference to be hosted in Dublin 
City in 2017. Meetings and consultations were held with 
key stakeholders to explore the interest and supports 
available to plan and deliver a successful conference and 
the potential topics and issues it might focus on. Through 
these meetings, it emerged strongly that the proposed 
conference in Ireland would be timely and welcome; it was 
especially pertinent, as the new National Drugs Strategy will 
be launched in 2017. Given the range and interdisciplinary of 
participants, speakers and topics at previous conferences, 
it also resonated with policy developments arising from the 
National Sexual Health Strategy2 and results in the 2014 Flash 
Eurobarometer survey of young adults aged 15–24 in EU 
member states.3 These were in relation to new psychoactive 
substances (NPS) consumption and use in Ireland as well as 
discussion of the Public Health (Alcohol) Bill 2015. With the 
enthusiastic support of stakeholders – such as the Health 
Research Board; Dublin City Council; UCD School of Social 
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3. Supply, access and availability pillar
  Aim: To challenge the environment in which alcohol is 
made available and accessed.
 Objectives:
• Educate communities in the law regarding sale and 
supply of alcohol.
• Review and challenge the current environment in 
which alcohol is available.
4.  Screening, treatment and  
rehabilitation pillar
  Aim: To increase the opportunity for people to access 
screening, treatment and rehabilitation services in Cork 
and Kerry.
 Objectives:
• Inform local communities of drug and alcohol 
services.
• Build the capacity of communities to implement 
screening and interventions in their areas.
• Improve access to drug and alcohol services for local 
communities, especially in rural areas.
5. Research pillar
  Aim: To conduct local research to support and underpin 
the Local Authority Action Plan.
 Objective:
• Conduct research that will inform up-to-date 
practice in relation to evidenced-based harm 
reduction.
6. Monitoring and evaluation pillar 
  Aim: To monitor and evaluate the implementation of the 
Local Alcohol Action Plan to inform ongoing development.
 Objectives:
• Continually monitor and evaluate the implementation 
of actions agreed with the Local Alcohol Action Plan.
• Continually monitor and evaluate the impact of our 
agreed actions.
Lucy Dillon
1 Cork and Kerry Alcohol Strategy Group (2016) Cork and Kerry 
alcohol strategy 2016–2018. Cork: Health Service Executive, 
Cork Local Drug & Alcohol Task Force, and Southern Regional 
Drug & Alcohol Task Force. http://www.drugsandalcohol.
ie/25693/
SERVICES 
Cork and Kerry 
Alcohol Strategy 
2016–2018
The Cork and Kerry alcohol strategy 2016–2018: time for 
change was launched in June 2016.1 It is the first for the  
area and was informed by a literature review of ‘alcohol  
and its influence at a global, national and local level’.  
This review is published as part of the strategy document. 
It includes literature from Ireland, the World Health 
Organization, and the European Union. In its conclusion, 
it identifies the introduction of minimum unit pricing, a 
reduction in availability, and increased restrictions on 
advertising and marketing as effective ways of reducing 
alcohol-related harms.
The strategy sets out its vision statement as ‘motivating the 
communities in Cork and Kerry to stop the damage caused 
by alcohol’, alongside its mission statement of ‘building 
capacity in local communities through an advocacy, research 
and evidence based approach to change our relationship 
with alcohol’. It has six pillars, each of which has an 
overarching aim. Each aim in turn is underpinned by a set of 
objectives with defined actions, leads, timeframes, and key 
performance indicators.
1. Overarching pillar
  Aim: To ensure that all actions are developed and 
implemented in the context of relevant national and  
local policy.
 Objectives: 
• Support the implementation of minimum unit pricing.
• Support the reduction in the availability of alcohol in 
local communities.
• Actively advocate for policy change and 
implementation to restrict the marketing of alcoholic 
products on a local, regional and national level.
• Include alcohol in the new national substance misuse 
strategy.
2. Education and prevention pillar
  Aim 1: To increase the awareness of the impact of alcohol 
harm within the wider community.
  Aim 2: To increase the general awareness of effective 
responses to alcohol harms at local level.
 Objectives:
• Actively promote a general awareness of alcohol 
harms.
• Deliver evidence-based education and prevention 
programmes across Cork and Kerry.
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UPDATES
Recent 
publications
The following abstracts are cited  
from published journal articles  
recently added to the repository of  
the HRB National Drugs Library at  
www.drugsandalcohol.ie  
Adolescent substance use in the 
context of the family: a qualitative 
study of young people’s views on 
parent-child attachments, parenting 
style and parental substance use
McLaughlin A, Campbell A and 
McColgan M (2016) Substance Use  
& Misuse. 51(14): 1846-1855  
http://www.drugsandalcohol.ie/26088/
Adolescent substance use can place 
youth at risk of a range of poor 
outcomes. This article aimed to explore 
risk and protective factors for youth 
substance use within the context of  
the family with a view to informing 
family based interventions. Nine 
focus groups supplemented with 
participatory techniques were 
facilitated with a purposive sample 
of sixty-two young people (age 13-
17 years) from post-primary schools 
across Northern Ireland.  
 
Conclusion: Parenting programmes 
(tailored to mothers and fathers) may 
benefit young people via components 
on authoritative styles, parental 
monitoring, communication, nurturing 
attachments and parent-child conflict. 
Youth living with more complex issues, 
e.g. parental substance misuse, may 
benefit from programmes delivered 
beyond the family environment, e.g. 
school based settings.
Overview of the European 
university-based study programmes 
in the addictions field
Pavlovska A, Miovsky M, Babor T and 
Gabrhelik R (2016) Drugs: Education 
Prevention and Policy Early online. 
http://www.drugsandalcohol.ie/26197/ 
We mapped and described university 
study programmes in the addictions 
field (USPA) in Europe, according to 
degrees, professional backgrounds, 
titles, methods of delivery, duration, 
entrance requirements, fees, clinical 
practice requirements and courses 
offered. 
Conclusion: In recent years, the 
number of specialised education 
programmes that aim to prepare a 
new professional workforce has been 
growing. The findings provide a basis 
for discussion and cooperation among 
programmes and universities.
Substance misuse and behavioral 
adjustment problems in Irish 
adolescents: examining contextual 
risk and social proximal factors
Fitzgerald A, Maguire J and  
Dooley B (2016) Substance Use  
& Misuse, 51(13): 1790-1809  
http://www.drugsandalcohol.ie/26022/ 
Using an ecological perspective to 
examine the roles of contextual factors 
and proximal social processes, the 
current study examined how family, 
peer, and school processes mediate 
the relationship between cumulative 
contextual risk and problem behavior, 
and whether these mediating 
relationships are moderated by gender. 
 
Conclusion: The study provides 
valuable and practical implications  
for informing research, interventions, 
and social policy at family, peer, and 
school levels.
‘Trip-sitting’ in the black hole:  
a netnographic study of dissociation 
and indigenous harm reduction
Hearne E and Van Hout MC (2016) 
Journal of Psychoactive Drugs,  
48(4): 233-242  
http://www.drugsandalcohol.ie/25845/
An array of dissociative novel 
psychoactive substances, including 
‘methoxetamine’, ‘3-MeO-PCP’, and 
‘methoxphenidine’, have emerged as 
substitutes for the illicit substance 
‘ketamine’. A netographic research 
methodology aimed to describe 
online, dissociative novel psychoactive 
substance users’ perceptions of risk, 
informed knowledge around use, and 
indigenous harm-reduction practices as 
advocated within online drug fora, so as 
to provide credible information which 
can be used to inform public online 
health education and drug prevention. 
Conclusion: Further research and 
consistent monitoring of Internet drug 
fora are advised to explore variations 
in harm-reduction tactics throughout 
dissociative NPS populations, and to 
consider how existing harm-reduction 
initiatives are influencing these hard-
to-reach groups.
Attitudes and perceived risk of 
cannabis use in Irish adolescents
Barrett P and Bradley C (2016)  
Irish Journal of Medical Science,  
185(3): 643-647  
http://www.drugsandalcohol.ie/25818/
Cannabis is the most widely used illicit 
drug in the developed world and its 
use is associated with several adverse 
physical and mental health effects and 
negative social outcomes. Earlier use of 
cannabis increases the risk of adverse 
effects. Attitudes and perceived risk 
towards drugs are regarded as strong 
influences in determining whether or not 
a person uses cannabis, but there is little 
existing research on Irish teenagers’ 
attitudes to the risks of this drug. This 
was a descriptive, cross-sectional 
study using a structured, anonymous 
questionnaire. 
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The study was undertaken in nine public 
and private secondary schools in Cork 
City and suburbs. Students aged 15-18 
and in fourth, fifth or sixth year of 
school were included. 
 
Conclusion: Cannabis use is very 
widespread among teenagers in Cork. 
There are relatively low levels of 
perceived risk of mental and physical 
health problems with use of the 
drug. Attitudes towards cannabis are 
associated with personal use of the drug 
and gender. 
Alcohol drinking cultures of 
European adolescents
Bräker AB and Soellner R (2016) 
European Journal of Public Health, 
26(4): 581-586  
http://www.drugsandalcohol.ie/25801/
Adolescent alcohol use varies across 
Europe. Differences in use might be 
due to variations in social drinking 
norms. These norms become apparent, 
e.g. in different proportions of alcohol 
drinking types per country. This 
study’s purpose is to cluster European 
countries according to prevalence 
rates of alcohol drinking habits 
among adolescents aged 12-16. The 
proportions of each drinking pattern 
per country (non, mild, episodic, 
frequent and heavy episodic use) 
across 25 European countries (N= 
48,423, M=13.83 years, 48.5% male) are 
used as classifying variables. 
 
Conclusion: When applying and 
developing intervention strategies, 
differences in adolescent alcohol 
drinking cultures (i.e. social drinking 
norms) within Europe should be 
focused on. Alcohol policies and 
prevention programs should take 
cultural aspects like social drinking 
norms into account.
RESPONSES 
General practitioners tackle 
complex addictions: how complex 
interventions can assist in dealing 
with addiction
Klimas J (2016) Irish Journal of 
Psychological Medicine Early online. 
http://www.drugsandalcohol.ie/26034/ 
Substance use disorder treatment is a 
complex problem. Complex problems 
require complex interventions, ideally 
tested via randomised controlled 
trials. Complex interventions are best 
developed in stages, using established 
implementation frameworks.
Conclusion: Starting with a historical 
patient case study, we explore how 
treatment of this challenging population 
group has been approached, how 
an evidence-based framework has 
informed formulation of a complex 
health intervention and how this has 
been progressed via the UK’s Medical 
Research Council (MRC) approach.
Estimating the cost-effectiveness 
of brief interventions for heavy 
drinking in primary health care 
across Europe
Angus C, Thomas C, Anderson P, Meier 
PS and Brennan A (2016) European 
Journal of Public Health Early online. 
http://www.drugsandalcohol.ie/26025/ 
Screening and Brief Interventions for 
alcohol are an effective public health 
measure to tackle alcohol-related 
harm, however relatively few countries 
across the European Union (EU) have 
implemented them widely. This may be 
due to a lack of understanding of the 
specific financial implications of such 
policies within each country.  
 
Conclusion: Implementing national 
programmes of SBI in primary health 
care would be a cost-effective means 
of reducing alcohol-attributable 
morbidity and deaths in almost all 
countries of the EU.
Effectiveness of pharmacotherapies 
in increasing treatment retention 
and reducing opioid overdose death 
in individuals recently released from 
prison: a systematic review
Crowley D and Van Hout MC (2016) 
Heroin Addiction and Related Clinical 
Problems Early online.  
http://www.drugsandalcohol.ie/25966/ 
Opioid dependence is common 
amongst the prison population, with 
increased risk of fatal overdose in 
the immediate post-release period. 
The study aimed to review the 
effectiveness of pharmacotherapies 
(Methadone (METH), Buprenorphine 
(BUP), levo-alpha acetyl methadol 
(LAAM), Naltrexone (NLT) and Naloxone 
(NLX)) in reducing overdose deaths 
and increasing treatment retention in 
opioid dependent prisoners on release.
Conclusion: The review underscores 
the need for prisoners on AOT to be 
supported with continued treatment 
on release into the community. Further 
research is warranted to investigate 
potential utility of long-acting NLT 
formulations and take-home NLX  
(THN) in pre–release opioid  
dependent prisoners.
Parenthood, child care, and heroin 
use: outcomes after three years
Comiskey CM, Hyland J and  
Hyland P (2016) Substance Use & 
Misuse, 51(12): 1600-1609  
http://www.drugsandalcohol.ie/25951/ 
Internationally there is a lack of 
measurement on the impact of 
childcare on people who use 
drugs. The aim of this article was 
to longitudinally measure drug use, 
familial and social status and criminal 
involvement between parents and 
nonparents who use heroin and have 
children in their care.
Conclusion: While caring for children 
was associated with reduced heroin 
use at 3 years, living with a person who 
used at intake removed this effect, 
thus indicating that while individual 
based addiction theories reflected 
observed outcomes, social network 
connectedness was more influential.
Variation between hospitals in 
inpatient admission practices for 
self-harm patients and its impact on 
repeat presentation
Carroll R, Corcoran P, Griffin E, Perry I, 
Arensman E, Gunnell D and Metcalfe C 
(2016) Social Psychiatry and Psychiatric 
Epidemiology Early online.  
http://www.drugsandalcohol.ie/25875/ 
Self-harm patient management varies 
markedly between hospitals, with 
fourfold differences in the proportion 
of patients who are admitted to a 
medical or psychiatric inpatient bed. 
The current study aimed to investigate 
whether differences in admission 
practices are associated with patient 
outcomes (repeat self-harm) while 
accounting for differences in patient 
case mix. 
 
Conclusion: No strong evidence was 
found to suggest medical admission 
reduces the risk of repeat self-harm. 
Models of health service provision 
that encourage prompt mental 
health assessment in the emergency 
department and avoid unnecessary 
medical admission of self-harm 
patients appear warranted. Psychiatric 
inpatient admission may be associated 
with a heightened risk of repeat 
self-harm in some patients, but these 
findings could be biased by residual 
confounding and require replication.
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17 Focused interventions for injecting 
drug users
Keane M and Hogarthy S (2016) World of 
Irish Nursing & Midwifery, 24(5): 66-67  
http://www.drugsandalcohol.ie/25820/ 
The authors discuss the need for 
supervised injecting facilities as a  
safer alternative to addicts injecting  
in public. 
The article particularly focuses on what 
supervised injecting facilities are and 
how injecting facilities operate.
Medical professionals’ perspectives 
on prescribed and over-the-counter 
medicines containing codeine: a 
cross-sectional study
Foley M, Carney T, Rich E, Parry C,  
Van Hout MC and Deluca P (2016)  
BMJ Open, 6(7): e011725  
http://www.drugsandalcohol.ie/25819/ 
Objectives were to explore prescribing 
practitioners’ perspectives on 
prescribed codeine use, their 
ability to identify dependence and 
their options for treatment in the 
UK. A cross-sectional design using 
a questionnaire was used with a 
nationally representative sample of 
300 prescribing professionals working 
in the UK. 
 
Conclusion: Communication with 
patients should involve assessment 
of patient understanding of their 
medication, including the risk 
of dependence. There is a need 
to develop extra supports for 
professionals including patient 
screening tools for identifying codeine 
dependence. The support structure for 
managing codeine-dependent patients 
in primary care requires further 
examination.
Effect of integrating HIV and 
addiction care for non-engaging 
HIV-infected opiate-dependent 
patients
Kinahan JC, Surah S, Keating S,  
Bergin C, Mulcahy F, Lyons F  
and Keenan E (2016) Irish Journal of 
Medical Science, 185(3): 623-628  
http://www.drugsandalcohol.ie/25816/ 
HIV-positive substance dependent 
patients contribute disproportionally to 
HIV morbidity and mortality as a result 
of poor compliance with their HIV 
treatment. This study aims to establish 
if integrating HIV and addiction care 
has a significant effect on addiction 
and HIV morbidity for non-engaging 
HIV-positive opiate-dependent 
patients. 
 
Conclusion: Integration of HIV and 
addiction care optimises the physical 
health of non-engaging HIV-positive 
opiate-dependent patients with no 
substantial effect on their methadone 
maintenance programme.
Determining rates of smoking 
cessation advice delivered during 
hospitalisation and smoking 
cessation rates 3 months post 
discharge: a two-hospital survey
Mellon L, McElvaney NG, Cormican 
L, Hickey A, Conroy R, Ekpotu L, 
Oghenejobo O, Atteih S, McDonnell R 
and Doyle F (2016) Health Psychology 
and Behavioral Medicine, 4(1): 124-137 
http://www.drugsandalcohol.ie/25796/ 
This study aimed to determine the 
prevalence of smoking and cessation 
advice received by inpatients in two 
teaching hospitals in Ireland, and the 
impact of cessation advice on smoking 
at 3 months post discharge.
Conclusion: This observational 
study finds that provision of brief 
cessation advice and smoking status 
documentation was suboptimal. Where 
advice was given, it was associated 
with enhanced motivation to quit and 
increased quit rates. These findings, 
along with low dependence scores, 
suggest that systematic provision of 
low-intensity cessation interventions 
could significantly enhance quit rates in 
hospitalised smokers.
Factors associated with non-
retention in HIV care in an era of 
widespread antiretroviral therapy
O’Connell S, O’Rourke A,  
Sweeney E, Lynam A, Sadlier C and 
Bergin C (2016) International Journal  
of STD & AIDS Early online  
http://www.drugsandalcohol.ie/25952/ 
In an era of antiretroviral therapy (ART) 
for all HIV-1-infected patients, our 
primary aim was to describe prevalence 
and characteristics of patients 
disengaged from care at an urban 
ambulatory HIV clinic. We conducted a 
nested case-control study. All patients 
who disengaged from care (defined 
as being lost to follow-up for at least 
one year) from 2007 to 2014 inclusive 
were identified. Cases were matched 
to controls in a 1:4 ratio. A total of 1250 
cases were included; 250/2289 (10.9%) 
of patients attending our HIV clinic 
disengaged from 2007 to 2014. One 
hundred and twenty-six (50.4%) were 
heterosexual, 81 (32.4%) were men who 
have sex with men and 40 (16%) were 
intravenous drug users.  
 
Conclusion: On univariate analysis 
only, patients with heterosexual risk 
were more likely to disengage from 
care. Those who disengaged were 
younger, mean age of 39. A higher 
proportion of patients who disengaged 
from care was not receiving ART and 
did not have a suppressed HIV-1 viral 
load. On multivariable analysis, Irish 
patients were less likely to disengage 
from HIV care. Factors associated with 
non-retention in HIV care have been 
identified. A semi-structured interview 
of those patients who re-engaged will 
take place to further examine reasons 
for disengagement from care. 
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